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Abstract 
Three types of human influenza virus (types A, B and C) are known. Influenza A and B 
cause a highly contagious respiratory disease in humans and domestic animals, and 
influenza C is associated with common cold-like symptoms, mainly in children. Although 
less virulent than influenza A virus, human influenza B virus also causes deaths and loss of 
productivity worldwide each year. Among the viral proteins, non-structural protein 1 
(NSl) is the most important viral regulatory factor during infection. The protein 
sequences of NSl from influenza A (NSl A) and influenza B (NSIB) have less than 20% 
identity and NSl from influenza C (NSIC) is even more distinct (<5% identity). NSl A 
and NSIB have different known functions and there is little information on the function of 
NSIC. To obtain a comprehensive view of the effect of NSl A, NSIB and NSIC proteins, 
quantitative real-time PCR (QRT-PCR) and microarray analyses using GeneChip arrays 
(Affymetrix) on human lung epithelial cell line NC1-H292 were performed. The 
contribution of NSl proteins in the perturbation of cytokines and other cellular genes were 
identified and compared. It has been demonstrated that NSl A alone was sufficient to 
regulate the host antiviral responses by inhibiting cytokines, interferons (IFNs), Janus 
kinase (JAK)-signal transducer and activator of transcription (STAT) pathway and other 
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antiviral genes. Interestingly, NSlA and NSIB proteins inhibited antiviral gene 
expression in human lung epithelial cells to different extent. NSl A protein was more 
efficient at blocking expression of cytokines and antiviral genes than N S l B and NSIC. 
This pointed to an immunosuppressive role of NSl . The strongest immunosuppressive 
effect of NSl A among the three NSl proteins investigated may explain the highest 
pathogenesis and severity of influenza A viruses. These findings further our 
understanding on the three NSl proteins and lay the foundation for developing new 






( N S 1 ) 是具有調控功能的蛋白，它能夠壓抑感染細胞所產生的干擾反應和 
促進病毒分子的製造。甲型、乙型和丙型流感病毒都有 N S 1 蛋白，甲型流 
感病毒中的N S 1蛋白（N S 1 A )與己型流感病毒中的N S 1蛋白（N S 1 B )及丙 
型流感病毒中的N S 1蛋白（N S 1 C )有很不同的氨基酸序列。N S 1 A與N S 1 B的 
氨基酸序列相同度少於百分之二十，而N S 1 A與N S 1 C的氨基酸序列只有少於 
百分之五相同� N S 1 A蛋白和N S 1 B蛋白有不同的已知功能，至於N S 1 C蛋白的 
功能，到現時仍是不太清楚。我們採用了微陣列（ M i c r o a r r a y ) 和即時聚 
合酶連鎖反應（ Q u a n t i t a t i v e r e a l - t i m e P C R )技術，發現N S 1 A � N S 1 B和 
NS1C蛋白對於人類肺部表層細胞中mRNA的表達有不同的影響。相對於NS1B 
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和N S I C蛋白，N S I A蛋白能更有效地抑制宿主的炎症性細胞激素的生產和免 
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1.1 Epidemics and pandemics of influenza virus 
Influenza virus causes a highly contagious respiratory disease in humans every year, and is 
responsible for periodic widespread epidemics, resulting in illness, death, social disruption 
and economic loss. The global annual influenza epidemics are believed to result in 3 to 5 
million cases of severe illness and 300,000 to 500,000 deaths (Harper et al., 2005). In the 
last 400 years, at least 31 influenza pandemics have been recorded (Lazzari et al., 2004). 
During the century, three influenza pandemics are known. They are the 'Spanish 
influenza', caused by a H l N l subtype in 1918, the 'Asian influenza' caused by a H2N2 
subtype in 1957 and the 'Hong Kong influenza' caused by a H3N2 subtype in 1968. 
These pandemics had high mortality rates. Recent studies have suggested that the 
mortality from the 1918 pandemic might be 50 to 100 million (Johnson et al., 2002). 
If a 1918-type influenza pandemic happens today, by translating the death toll associated 
with the 1918 influenza virus to the current population, it would cause 180 to 360 million 
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deaths worldwide (Osterholm et aL, 2005). According to a report by the World Health 
Organization (WHO), in industrialized countries alone, the next influenza pandemic may 
result in up to 130 million outpatient visits, two million hospital admissions and 650,000 
deaths in two years. The impact may be even greater in developing countries (WHO, 
2004). 
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1.2 Biology of influenza virus 
1.2.1 Types of influenza virus 
Three types of human influenza viruses (types A, B and C) are known. Among these 
viruses, type A influenza viruses are the most pathogenic. Wild birds are the natural host 
for influenza A virus. Influenza A virus can infect people, birds, pigs, horses, and other 
animals. The H l N l virus causing the Spanish influenza pandemic in 1918 is an example 
of pathogenic influenza A virus. On the other hand, influenza B virus is found in humans 
and seals only. Although influenza B virus can cause death in humans, it is associated 
with less severe epidemics than influenza A virus and has not caused any pandemics. 
Unlike influenza A and B viruses, influenza C virus only causes mild illness in humans, 
mainly in children, and has not caused any epidemics or pandemics. 
Influenza A virus is further classified by subtypes according to the differences between two 
main surface glycoproteins: hemagglutinin (HA) and neuraminidase (NA). For example, 
an "H3N2" virus represents an influenza A subtype that has a HA 3 protein and a NA 2 
protein. Subtypes of influenza A virus currently circulating among people worldwide 
include H l N l , H1N2, and H3N2 viruses. Other subtypes are found in other animal 
species. The H l N l virus causing the Spanish influenza pandemic in 1918 and the deadly 
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H5N1 virus transmitted from chickens to humans in Hong Kong in 1997 are examples of 
highly pathogenic influenza A subtypes. 
Influenza A, B and C viruses are further classified by strains. Many different strains of 
influenza A subtypes and influenza B viruses have been identified. New strains of 
influenza virus appear through the process of antigenic drift (Section 1.2.4). New stains 
will constantly replace old strains. 
1.2.2 Viral structure and viral proteins 
Influenza virus belongs to the family Orthomyxoviridae. It is an enveloped, 
negative-stranded RNA virus. Genome of influenza A virus consists of eight RNA 
segments, encoding for 10 proteins: envelope glycoproteins HA and NA, matrix protein 
(Ml), nucleoprotein (NP), three polymerase proteins (PBl, PB2 and PA), ion channel 
protein (M2) and non-structural proteins (NSl and NS2) (Lamb & Krug., 1996; Portela et 
al., 1999). The genome of influenza A virus is organized into eight ribonucleoprotein 
(RNP) complexes, each containing viral RNA (vRNA) molecule, NP and polymerase 
complex consisting of three polymerase subunits. 
Genome of influenza B virus also consists of eight RNA segments organized in RNP 
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complexes. Although influenza B virus has a high degree of homology with influenza A 
virus, it expresses several unique proteins including membrane proteins NB and BM2 
(Brassard et al., 1996; Horvath et aL, 1990). 
Unlike type A and B influenza viruses, genome of type C influenza virus consists of only 
seven RNA segments encoding three polymerase proteins (PBl , PB2, and PBS), 
hemagglutinin-esterase (HE) glycoprotein, nucleoprotein (NP), matrix (Ml) protein, and 
two nonstructural proteins (NSl and NS2) (Lamb & Takeda, 2001). As for type A and B 
influenza viruses, each vRNA molecule in influenza C virus is associated with NP and three 
polymerase subunits (PBl , PB2, and PBS) to form the RNP complex (Crescenzo-Chaigne 
et al., 1999). 
1.2.3 Life cycle of influenza virus 
Influenza virus replicates in the epithelial cells of the upper respiratory tract. Sialic acid 
containing surface glycoproteins on cell membrane function as receptors for influenza virus. 
Influenza A virus enters the cell by endocytosis via clathrin-dependent endocytotic pathway. 
The fusion of viral and endosomal membrane is triggered by low pH in endosomes. After 
the fusion, viral RNP is liberated into cytoplasm. The nuclear localization signal (NLS) of 
the RNP directs the translocation of RNP into nucleus, where the synthesis of primary 
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messenger RNA (mRNA) is initiated by viral RNA polymerase complex. Viral mRNA are 
then transported to cytoplasm, and translated into viral proteins. The newly synthesized 
polymerase proteins and NP are transported into nucleus, where they initiate the synthesis 
of complementary RNA (cRNA) from vRNA, followed by synthesis of new vRNA. The 
newly synthesized vRNA acts as template for secondary mRNA synthesis, which is also 
catalyzed by the viral polymerase complex (Lamb & Krug, 1996; Portela et al,, 1999). 
Viral mRNAs are transported to cytoplasm and viral structural proteins are synthesized. 
Polymerase proteins and NP are then transported back to nucleus, where they assemble 
with vRNA to form viral RNP. Ml and NS2 proteins are also transported into nucleus to 
regulate the nuclear export of newly synthesized viral RNP (Gomez-Puertas et al., 2000; 
Lamb & Krug, 1996). Interaction of viral RNP-Ml protein complex and cytoplasmic HA 
and NA envelope proteins triggers budding of mature virions (Lamb & Krug, 1996). The 
viral progenies lyse the infected cell and are released from it with the help of NA (Portela & 
Digard, 2002). All three types of influenza viruses share same replication strategies, 
except that their surface glycoproteins are different. 
1.2.4 An ever-changing virus 
Influenza viruses are dynamic. They undergo genetic variation by two mechanisms: (1) 
antigenic drift, which happens all the time, and (2) antigenic shift, which only happens 
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occasionally. Influenza A virus undergoes changes by both ways, while influenza type B 
and C viruses only change by antigenic drift. 
Antigenic drift is an unpredictable and gradual process. It is characterized by small, 
gradual changes caused by point mutation in the antigenically important HA and NA genes, 
resulting in small changes in these surface glycoproteins. Antigenic drift produces new 
virus strains. These new strains may not be recognized by antibodies against earlier 
strains, therefore, people can be repeatedly infected with influenza viruses. In order to 
select the strains for the annually-produced influenza vaccine, global surveillance is needed 
to monitor the evolution of strains of human influenza virus. 
Unlike antigenic drift, antigenic shift is a sudden process, causing major change to produce 
a new influenza A subtype. Antigenic shift can occur by a substitution of a whole gene 
from one subtype to another, either through direct animal-to-human transmission or 
through genetic reassortment of human influenza A and animal influenza A virus genes. 
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1.3 Pathogenesis and immunology of influenza virus 
1.3.1 Diseases and symptoms caused by influenza virus infection 
The common initial symptoms of influenza infection in humans are high fever, pneumonia, 
pharyngitis, conjunctivitis and acute encephalitis (Tran et al., 2004; Yuen et al” 1998; 
Yuen & Wong 2005). Adult patients with initial signs of pneumonia might progress to an 
Acute Respiratory Distress Syndrome (ARDS)-like disease. In fatal cases of H5N1 
influenza virus, a prominent feature is the reactive hemophagocytic syndrome. 
Extrapulmonary involvement has also been described as extensive hepatic central lobular 
necrosis, acute renal tubular necrosis and lymphoid depletion (To et al., 2001). 
The respiratory symptoms in influenza virus infection include hyperreactivity of the 
bronchial system (Little et al., 1978; Utell et al., 1980), obstruction predominantly of small 
airways (Hall et al., 1976) and impaired diffusion capacity (Horner et al., 1973). Human 
influenza virus infection usually appears with extended inflammation in lower and upper 
respiratory tract with loss of ciliated cells, resulting in hyperemic or hemorrhagic hyaline 
membranes and infiltrates of neutrophils and mononuclear cells (Yeldandi & Colby, 1994). 
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Hyperreactivity might be a result of release of pro-inflammatory cytokines (Tsitoura et al., 
2000). 
Human influenza virus infection also causes complex cytopathic effects, predominantly at 
the epithelial cells in respiratory tract, resulting in acute disease of lung and airways. 
Influenza virus infection and replication in the respiratory tract inhibits host cell protein 
synthesis, leading to cell damage (Katze et al., 1986, Sanz-Esquerro et al., 1995) and 
apoptosis (Wiley et al., 2001). Apoptosis is triggered by different mechanism and is 
characterized by morphological changes including loss of mitochondrial function, 
cytoskeleton disruption, DNA fragmentation, condensation of cytoplasm and chromatin and 
formation of small membrane bound particles known as apoptotic bodies. 
1.3.2 Production of cytokines during influenza virus infection 
Upon influenza virus infection, cytokines and chemokines are produced locally or 
systemically by epithelial and immune cells of the respiratory mucosa after interaction with 
influenza virus. Cytokines and chemokines are local hormones modulating activities of 
cells in the immune system. Chemokine family consists of more than 40 proteins. They 
25 
bind to specific cell surface receptors on leukocytes, enabling them to migrate from blood 
vessels into the sites of inflammation (Zlotnik et al., 2000). Influenza A virus-infected 
macrophages and epithelial cells are found to secret chemokines, pro-inflammatory and 
immunoregulatory cytokines including IFNs, tumor necrosis factor (TNF)-a, macrophage 
inflammatory protein ( M l P ) - l a , MIP- lp , MIP-3a, RANTES, interleukin ( IL) lp , IL6, IL8 
and IFN-inducible protein (IP)IO (Bussfeld et al., 1998; Gong et al., 1991; Matikainen et 
al., 2000; Nain et al., 1990; Piirhonen et al., 1999; Ronni et al., 1995; Sareneva et al, 1998; 
Sprenger et al., 1996). Most of these cytokines have been detected in nasopharyngeal 
washes of influenza viruses-infected patients (Brydon et al., 2005). 
Some cytokines like IFNs, TNF-a/p , IL - l a /p , IL-6, IL-8, and M l P - l a are involved in the 
pathogenesis of fever. The Hong Kong 1997 H5N1 has been proposed to potently induce 
pro-inflammatory cytokines including IFN-P, TNF-a , RANTES and IL-6 (Chan et al., 2005; 
Cheung et al., 2002). It has been postulated that the initial virus replication in the 
respiratory tract triggers hypercytokinemia and complicated by a reactive hemophagocytic 
syndrome. This syndrome is different from that of other usual human subtypes (To et al., 
2001). 
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1.3.3 Immune responses in the hosts 
Influenza virus infection initiates a cascade of host immune reactions, including influx of 
neutrophil granulocytes or natural killer cells (Mandelboim et al., 2001) and release of 
cytokines (IFN-a, IFN-p and TNF-a). Innate immunity is important in two ways: (1) it 
limits the initial viral spread and replication; and (2) it induces co-stimulatory molecules to 
activate antigen-specific lymphocytes of the adaptive immune response during the 
host-virus interaction. Adaptive immune response requires several days to become 
effective. After it has developed, it helps to eliminate the virus, and to establish a 
long-lasting resistance to re-infection with homologous virus. Influenza virus infection 
induces systemic and local antibody (humoral immunity), as well as cytotoxic 丁 cell 
responses (cellular immunity). Both of them are important in recovery from acute 
infection and resistance to re-infection. 
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1.4 Non-structural protein 1 (NSl) 
L4.1 Overview of NSl 
Except NSl and PB1-F2, which is encoded by an alternative reading frame of the PBl 
polymerase gene, all of the proteins in influenza viruses are structural proteins. NSl 
protein gets the name 'non-structural' because it is not incorporated into the virions. It is 
synthesized in infected cells only (Yuan & Krug, 2001). NSl protein is encoded by the 
smallest RNA segment in influenza virus. This segment also encodes nuclear export 
protein or NS2 from a spliced mRNA. NSl protein is present in influenza A, B and C 
viruses. All of them are acidic proteins with pi values less than 6. Basic information of 
NSIA, NSIB and N S I C are summarized in Table 1.1. NSl proteins from different 
subtypes of type A influenza virus show high homology, while NSIB (< 20%) and NSIC 
(< 5%) show low similarity with NSIA. The alignment of NSIA, NSIB and NSIC are 
shown in Figure 1.1. 
NSl is a multifunctional protein. It binds to double-stranded RNA (dsRNA) through its 
N-termina丨 domain and to specific protein targets. Two important domains have been 
described in NSIA and NSIB proteins: the N-terminal RNA-binding domain (RBD) and 
the C-terminal effector domain. It has been revealed that, for NSIA, the effecter domain 
is crucial for the function of the RBD (Krug et al., 2003; Wang et al., 2002), and that 
28 
dimerization of these two domains is essential for cellular proteins and RNA binding of 
NSIA (Figure 1.2). For NSIC, since it has not been well characterized, comparatively 
little information about its roles and structure is known. 
1.4.2 Roles of NSl in influenza virus infection 
NSIA is a multifunctional protein. It has been shown to affect a variety of host cell 
functions in multiple levels to facilitate viral survival and replication. In 
post-transcriptional level, by blocking nuclear export of polyadenylated cellular transcripts 
(Fortes et al., 1994; Qiu et al., 1994; Satterly et al., 2007), NSIA inhibits host cell mRNA 
processing (Lu et al., 1994). In translational level, by forming a trimeric complex with 
eukaryotic translation initiation factor eIF4GI and poly(A)-binding protein I (PABI), it 
enhances the initiation of translation of viral mRNAs (Burgui et al., 2003). In protein 
level, through its N-terminal RBD, it binds and sequesters dsRNA away from host antiviral 
proteins (Donelan et al., 2003; Wang et al., 1999). The sequestration of RNA prevents 
activation of the transcription factors I FN regulatory factor (IRF) 3, IRF7, nuclear 
factor-kappa B (NF-KB), and c-Jun/ATF2, and thus prevents activation of 2'-5' 
oligoadenylate synthetase (OAS)/RNase L system (Min et al., 2006), N F - K B signaling 
pathway and other antiviral signaling pathways. Being able to sequestrate small 
interfering RNA (Bucher et al., 2004; Li et al., 2004), NSIA can also suppresses the 
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induction of RNA interference. Apart from that, through binding to protein kinase R 
(PKR), which regulates host protein synthesis, and phosphatidylinositol 3-kinase (PI3K), 
NSl A has a direct enhancing effect on viral replication (Hale et al,, 2006; Li et aL, 2006). 
In addition, NSl A proteins of some virus strains have been shown to suppress the antiviral 
function of IFNs and TNF-a (Geiss et aL, 2002; Hay man et al., 2006; Seo et aL, 2002). 
Both NSl A and N S I B bind dsRNA via their N-terminal RBDs (Wang & Krug, 1996) and 
can act as I FN antagonists and inhibit the IFN-inducible PKR (Dauber et aL, 2004). 
Besides these similar roles, other functions differ markedly. In contrast to NSl A, NSIB is 
not able to induce PI3K signaling, which prevents premature apoptosis during viral 
propagation (Ehrhardt et aL, 2007), and is not able to inhibit polyadenylation, splicing, and 
nuclear export of cellular mRNA (Wang & Krug, 1996), but it has the distinctive ability of 
binding to ISG15 protein, an anti-viral protein, and to inhibit its conjugation to cellular 
targets (Yuan et al., 2001; Yuan et al., 2002). 
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Table 1.1. Basic information of NSIA, NSIB and N S I C proteins. 
Protein Size (kDa) Number of amino Domain 
acid residues 
N S I A ^ RNA-binding domain: aa 1-73 
Effecter domain: aa 74-230 
N S I B ^ ‘ m RNA-binding domain: aa 1-93 
Effecter domain: aa 94-281 
N S I C ^ m / 
NSIA HDSNTVSSFQVDCFLTJHVRKRFADQELGDAPFLDRLRRDQKSLRGRGS 48 
NS1B MANNMTTTQIEVGPGATMATINFEAGILECYERLSUQRALDYPGQDRLNRLKRKLESRIK 60 
NSIC HSDKTVKSTNLHAFVAT一一KHLERQEDLDTCTEHQVEKHKTSTKARLR 46 
卞 • • • • • 方 玄 fr 
• • • • 
NSIA TLG LDIRTATREGKHIVERILEEESDEALK HTIASVPAPRY 89 
NS1B THNKS EPESKRHS L E E RKAIGVKKHKVL LF MNP SAGIEGFEPYCHKSSSNSNCTKYWUTD 120 
NSIC TEFSFAP RTITE DAIKDGELL FNGTIL QAE S P THT P ASVE HRGKKL P ——92 
* . : • : 
NSIA ——L TE HTL E E MS RD - TJL ML IP KQKVTGS LCI RHD Q AI HD KD11L K AI'J- - F SVIFNRL E A 143 
NSIB YPSTPGRCLDDIEEEPEDVD GP TEIVLRD HNWKD ARQKIKEEVNTQKE GKFRLTIKRDHP. 180 
NS 1C -IDFAPSNIAP工GQNP lYLSPCIPNFDGNVUEATI.IYHHRGATLTKTI.IN--CNCFQRTIIiJC 149 
• • 霧 • _ • • • • • _ 
NS lA LILL RAF TDEGAIVGE ISPLPSLPGHTEE D VKN- - AIGVLIGGL E UIsTDNTVRVS E T 197 
NSIB NVLSLRVLVWGTFLKHPNGYKSLSTLHRLNAYD — QSGRLVAKLVATDDLTVEDEEDGHR 238 
NSIC HPMPSRMRLSYJlFVLYCPJJTKKICGYLIARQVAGIETGIRKCFRCIKSGFVHATDEISLT 209 
• _ • • "fr • 
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NSIC ILRSIKSGAQLDPYTJGNETPDIDKT EAYHLSLREAGP 246 
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Figure 1.1. Alignment of NSIA, NSIB and NSIC proteins. Alignment was done by 




Figure 1.2. Model for N S I A protein dimer (Lin et al., 2007). The red, gold and blue 
areas represent RNA, RNA-binding domain dimer and effecter domain dimer respectively. 
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1.5 Aims of study 
The aims of this study are: (1) to understand the importance of NSl A and NSIB on 
antiviral responses in host cells and (2) to understand the different activities of NSl A, 
N S l B and N S I C on cytokine gene expression. By knowing more about the different 
action of these NSl proteins, we hope to further understand the pathogenesis of NSl A and 
to suggest potential targets to enable early diagnosis and effective antiviral treatment of 
influenza virus infection. 
To achieve these aims, a global gene expression study was performed to identify host cell 
gene expression profiles triggered by NSl A and NSIB proteins (Chapter 3). In addition, 
gene expression of different cytokines in responses to NSl A, NSIB and NSIC proteins 
were found (Chapter 4). By comparing the gene expression profiles, we could understand 
more about different action of NSIA, NSIB and NSIC proteins, and might explain the 
virulence and pathogenesis of influenza A virus. 
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Chapter 2 
Materials and Methods 
2.1 Materials 
2.1.1 Chemical reagents 
Table 2.1. List of commonly used chemicals 
Chemical Reagent Formula Weight Source 
2-mercaptoethanol (p-ME) 
78.1 Sigma, USA 
(C2H6OS) 
Acrylamide / Bis-acrylamide; 
/ Sigma, USA 
30% solution, mix solution 37.5:1 
Agarose powder / Sigma, USA 
Ammonium Persulfate (APS) 
228.2 Serva, USA 
((NH4)2S208) 
Amersham Pharmacia, 
Anti-rabbit IgG, HRP-Conjugated, Goat / 
Uppsala, Sweden 
Bromophenol Blue 




119.4 Sigma, USA 
(CHCI3) 
Deoxynucloetides (dNTP) / Novagen, Germany 
Ethanol 
46.1 Merck, Germany 
(CH3CH2OH) 
Ethidium Bromide (EtBr) 394.0 Amresco, USA 
Ethylenediaminetetraacetic Acid (EDTA) 
292.2 Sigma, USA 
(C10H16N2O8) 
Gene Ruler™ DNA Ladder Mix / Invitrogen, USA 
Glycine 
75.1 USB, USA 
(H2NCH2CO2H) 
Hydrochloric Acid 
36.5 BDH, England 
(HCl) 
Isopropanol 
60.1 BDH, England 
( ( C H 3 ) 2 C H 0 H ) 
LB agar / USB, USA 
LB broth / USB, USA 
MES hydrates 
195.2 Sigma, USA 
(C6H13NO4S . XH2O) 
MES sodium salt 
217.2 Sigma, USA 
(C6H,2NNa04S) 
Methanol 
32.1 Merck, Germany 
(CH3OH) 
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N,N,N',N-Tetramethyl-Ethylene - Diamine 
116.2 Bio-Rad, USA 
(TEMED) ((CH3)2NCH2CH2N(CH3)2) 
, Non-Fat Milk / Nestle, HKSAR, China 
Polyoxyethylene-Sorbitan Monolaurate 
/ Sigma, USA 
(Tween-20) 
Pre-stained SDS-PAGE Standards / Bio-Rad, USA 
Potassium Chloride 
74.6 USB, USA 
(KCl) 
Potassium Phosphate 
136.1 Sigma, USA 
(KH2PO4) 
Sodium Chloride 
58.4 USB, USA 
(NaCl) 
Sodium Dodecyl Sulfate (SDS) 
288.4 USB, USA 
(CH3(CH2)iiS04Na) 
Sodium Hydrogen Phosphate 
142.0 Sigma, USA 
(Na2HP04) 
Sodium Hydroxide 
40.0 Sigma, USA 
(NaOH) 
Streptavidin Phycoerythrin (SAFE) / Molecular Probes 
Tris 
121.1 USB, USA 
(NH2C(CH20H)3) 
TRIzol 60.1 Invitrogen, USA 
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2.1,2 Buffers 
2.1.2.1 Preparation of buffers 
Buffer was prepared by dissolving chemicals in distilled water (dH�。）and calibrated to 
suitable pH using either HCl or NaOH, unless otherwise specified. 
2.1.2.2 Commonly used buffers 
RFl (competent cell preparation) 
30 mM KAc, 100 mM RbCh, 10 mM CaCh, 50 mM MnCh, 15% glycerol. pH was 
adjusted to 5.8 by HAc and no back titration was performed. The solution was sterilized by 
filtration through a 0.2 \im filter. 
RF2 (competent cell preparation) 
10 mM MOPS, 75 mM CaCh, 10 mM RbCh, 15% glycerol. pH was adjusted to 6.5 with 
KOH and the solution was sterilized by filtration through a 0.2 \im filter. 
6X DNA loading buffer 
0.25% (w/v) bromophenol blue，40% (w/v) sucrose and 0.25% (w/v) xylene cyanol FF. 
The buffer was stored at 4 °C. 
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SOX TAE buffer stock 
2 M Tris-acetate and 50 mM EDTA. It was stored at room temperature. 
LB broth 
20 g of LB broth powder (USB) was added to IL dH20. The solution was sterilized by 
autoclave. Ampicillin and chloramphenicol are used at 100 jug/ml and 50 jag/ml (final 
concentration), respectively. 
LB agar plate 
35 g/L LB agar powder (USB) was added to IL dHiO. The solution was sterilized by 
autoclave. Antibiotics were added to the agar media when their temperature fell below 60�C. 
Ampicillin were used at 100 |ig/ml (final concentration). The agar media were then poured 
to Petri dishes of appropriate sizes. 
PBS 
1 mM KH2PO4, 10 mM Na2HP04, 0.137 M NaCl, 2.7 mM KCl, pH 7.4. 
20XSSPE 
3 M NaCl, 0.2 M NaHsPOg, 0.02 M EDTA. 
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Lysis buffer 
2% SDS, 10% glycerol, 0.0625 M Tris/HCL, pH 8.0. 
SDS running buffer 
25 mM Tris base, 192 mM glycine and 0.1% (w/v) SDS. 
6X SDS loading buffer 
12% (w/v) SDS, 375 mM Tris-HCl, 60% (v/v) glycerol and 0.01% bromophenol blue, 
calibrated to pH 6.8. The buffer was supplemented with 5% (v/v) P-ME and was stored at 
4 0 c . 
Transfer buffer 
48 mM Tris base, 39 mM glycine, 20% (v/v) methanol and 0.0375% (w/v) SDS. pH was 
adjusted to the range 9.2 to 9.4. 
Tris-buffered saline with Tween-20 (TEST) 
10 mM Tris base, 0.15 M NaCl and 0.1% (v/v) Tween-20. 
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2.1.3 Strains and plasmids 
The NSl cDNA from influenza A/Hong Kong/156/97(H5Nl), influenza B/Hong 
Kong/692/01 and influenza C/Hong Kong/6/07 were obtained from Prof. Paul Chan of 
Department of Microbiology, The Chinese University of Hong Kong. They were used as 
templates for polymerase chain reaction (PCR). After amplification, the DNA was 
inserted into a human expression vector pCIneo (Promega). Escherichia coli {E. coli) 
strain D H 5 a (Novagen) was used for plasmid DNA amplification. 
2.1.4 Primer list 
Primers were designed to anneal at the template for more than 15 nt to ensure proper 
annealing in PCR. The primers are either 'forward' (5' to 3' with respect to the reading 
frame) or 'reverse' (3' to 5' with respect to the reading frame). Restriction sites were 
underlined. The following lists the sequences of the forward (F) and reverse (R) primers: 
1. NSIA-F. 




Reverse primer that anneals at the C-terminus of the coding sequence of NSl A. 
GTGGTGGCGGCCGCTCAAACTTCTGGCTCAAT 
3. NSIB-F. 
Forward primer that anneals at the N-terminus of the coding sequence of NSl B. 
GTGGTGGAATTCATTGAGGTGGGTCCGGGA 
4. NSIB-R. 
Reverse primer that anneals at the C-terminus of the coding sequence of NSl B. 
GTGGTGGCGGCCGCCTAATTGTCTCCCTCTT 
5. NSIC-F. 
Forward primer that anneals at the N-terminus of the coding sequence of NSIC. 
GTGGTGGAATTCAGTCAAATCAACAAATTT 
6. NSIC-R. 




2.2.1 Preparation of competent cells 
Competent cells E.coli DH5a from -80°C glycerol stock were streaked to an LB agar plate 
and the plate was incubated at 37°C overnight. Starter culture was prepared by picking a 
single colony and inoculated into 5 ml LB medium. The culture was shaken at 37°C with 
250 rpm until ODeoo reached 0.3. The culture was then transferred into 100 ml of LB 
medium and continued shaking at 37°C until ODeoo reached 0.45. The cells were 
collected and placed on ice for 5 min. The cells were then collected by centrifugation at 
8000 rpm for 10 min at 4°C (Beckman JA-16.250 rotor). The cell pellet was resuspended 
in 40 ml of RFl and kept on ice for 5 min. The cells were recentrifuged and the pellet was 
resuspended in 4ml of RF2. The suspension was kept on ice for 15 min and divided into 
100 1 aliquots and snap-frozen in liquid nitrogen. The cells were stored at -80°C until 
use. 
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2.2.2 Molecular cloning 
2.2.2.1 Amplification of the target genes by PCR 
PCRs were used to amplify and add restriction sites to the target genes. A pair of primers 
was designed to anneal to the DNA template. The primers acted in a forward (5，to 3' 
with respect to the reading frame) and reverse (3' to 5' with respect to the reading frame) 
pair. The primers were designed to have a GC content of about 50% and no 
self-complementation occurred between the primer pairs. PCRs were performed to 
amplify the target genes. Composition of reaction mixture and the general reaction 
scheme are listed in Tables 2.2 and 2.3 respectively. The reactions were carried out by 
KOD DNA polymerase (Novagen, Germany) in 500 |LI1 Eppendorf tubes in a MJ PTC-100 
thermocycler, where lid heating was available. The resulting DNA products were 
analyzed by agarose gel electrophoresis or stored at -20°C. 
2.2.2.2 Agarose gel electrophoresis 
1.0 % (w/v) agarose gel was prepared by dissolving 0.3 g of agarose in 30 ml of IX TAE 
buffer, with 1 |il of ethidium bromide (10 mg/ml) added. PCR products were mixed with 
6X DNA loading buffer to give a final concentration of IX. The gel was submerged into 
a gel tank containing IX TAE buffer. After loading the samples and Gene Ruler™ DNA 
Ladder Mix (Invitrogen, USA) into the wells, electrophoresis was performed with a 
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constant voltage of 100 V. The agarose gel was then placed onto a Spectroline TC-302 
transilluminator (302 nm) for visualization of DNA. 
2.2.2.3 Extraction and purification of DNA from agarose gels 
The steps were modified from the manual provided by the manufacturer (GeneClean III Kit, 
Bio Lab 101 Inc.). Desired DNA fragment was excised from the gel under the 
illumination of a Spectroline UV transilluminator. 500 |LI1 of GEX buffer was added to the 
Eppendorf tube containing the gel slice. The mixture was incubated in 60 °C for about 10 
min until the gel completely dissolved. A column was placed onto a collection tube and a 
maximum of 700 |li1 of gel mixture was loaded onto the column. The column was then 
centrifuged at 9000 rpm by desktop centrifuge (Minispin, Eppendorf) for 1 min. The 
flow-through was discarded. The procedures were repeated for the rest of the gel mixture. 
Next, the column was washed with 500 \i\ of WF buffer and then centrifuged at 9000 rpm 
for 1 min. The flow-through was discarded. After that, the column was washed with 
700 |il of WS buffer, which contain ethanol, and then centrifuged at 9000 rpm for 1 min. 
Flow-through was discarded. As residual ethanol could affect the quality of DNA and 
inhibit subsequent enzymatic reaction, 3 more min of centrifugation at 13000 rpm was 
performed to ensure all residual ethanol was removed. After that, the column was placed 
into a new eppendoff tube and 40 |LI1 of warm water was added onto the column membrane. 
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It was allowed to stand under room temperature for 5 min. DNA was then eluted through 
centrifugation at 13000 rpm for 2 min. DNA eluted was used for the next step or stored at 
-20�C. 
2.2.2.4 Restriction digestion of DNA 
The DNA insert prepared by using the 'Gene Clean' kit and the pCIneo vector were 
digested by restriction enzymes, EcoK\ and Not\, at 37 ^C for 2 hours. Detailed 
conditions for restriction digestion are listed in Table 2.4. After digestion, 6X DNA 
loading dye was added to stop the reaction and the reaction mixture was analyzed by 
agarose gel electrophoresis as described in section 2.2.2.2. Desired DNA fragment was 
extracted and purified from the gel by GeneClean III kit as described in section 2.2.2.3 for 
subsequent ligation. 
2.2.2.5 Ligation of digested insert and expression vector 
The digested insert and vector retrieved from the gel were ligated at correct reading frame 
by T4 DNA ligase in a 20 |li1 reaction mixture at 16 for 16 hours as listed in Table 2.5. 
The digested insert and pCIneo vector were mixed in a molar ratio of about 3:1. 
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2.2.2.6 Transformation and plating out transformants 
Ligation product was transformed into freshly thawed E.coli strain DH5a competent cells 
for plasmid amplification. 5 of ligation product was added to the Eppendorf tube 
containing 100 of the competent cells and incubated on ice for 30 min. After that, it 
was incubated at 42 °C and heat shocked for exactly 1.5 min, and then kept on ice for 10 
min. 500 \i\ of LB medium was then added, and the cells were incubated at 37 for 45 
min with constant shaking at 250 rpm for recovery. The cells were then centrifuged at 
8000 rpm for 1 min. Supernatant was discarded and cell pellet was resuspended in 100 
of LB medium. The resuspended cells were then spread evenly onto a LB agar plate 
containing 100 )ag/ml of ampicillin. The plate was incubated at 37 °C for 16 hours. 
2.2.2.7 Verification of insert by PGR 
10 single colonies on the plate were selected. Each time one of the 10 selected single 
colonies was picked by a toothpick. The toothpick was soaked into the PCR mixture to 
dispense the colony. For the other nine colonies, the same procedures were repeated. 
After that, PCR was performed. The composition of PCR reaction mixture and the PCR 
reaction scheme are listed in Table 2.6 and 2.7 respectively. PCR products were then 
analyzed by agarose gel electrophoresis to check for the size. 
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2.2.2.8 Mini-preparation of plasmid DNA 
Single clone was picked and inoculated into 5 ml of LB medium containing 100 fig/ml of 
ampicillin and incubated at 37 °C for 16 hours with constant shaking at 250 rpm. Steps of 
plasmid extraction were modified from the manual provided by the manufacturer (Wizard 
Plus SV Minipreps DNA Purification Kit, Promega). First, overnight bacterial culture was 
centrifuged at 13000 rpm by a desktop centrifuge (Minispin, Eppendorf) for 1 min. 
Supernatant was discarded. 250 |u,l of MXl buffer was added to resuspend the cell pellet. 
250 |il of MX2 buffer was then added and the tubes were inverted gently for several times 
until the lysate became clear. The mixture was incubated at room temperature for 1 to 5 
min. After that, 350 jil of MX3 was added. The mixtures were mixed immediately by 
inverting for several times until white precipitates formed. The resulting lysate was 
centrifuged at 13000 rpm for 10 min. After centrifugation, supernatant was transferred to 
a DNA-binding column sitting on the collection tube, and centrifuged at 9000 rpm for 1 
min. Flow-through was discarded. After that, 500 |il of WF buffer was added and 
centrifuged at 9000 rpm for 30 s to wash the column. Flow-through was discarded. 700 
|il of WS buffer was then added and centrifuged at 9000 rpm for 30 s to wash the column. 
Flow-through was discarded. As any residual ethanol could affect the quality of DNA and 
inhibit subsequent enzymatic reactions, 3 more min of centrifugation at 13000 rpm was 
performed to ensure all residual ethanol had been removed. Finally, the column was 
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transferred to a clean Eppendorf tube. 40 fil of warm water was added onto the column 
membrane. The tube was allowed to stand under room temperature for 5 min, and 
centrifuged at 13000 rpm for 2 min. The eluted DNA was stored at -20"C for later use. 
2.2.2.9 Confirmation of insertion in the miniprep DNA by restriction digestion 
It was done by restriction enzyme digestion of the plasmid DNA to yield the original inserts. 
Restriction digestion was performed in a volume of 20 fil at 37 for 2 hours. Details of 
the reaction mixture are listed in Table 2.8. After digestion, 6X DNA loading dye was 
added to stop the reaction and the size of insert was checked by agarose gel electrophoresis 
as described in Section 2.2.2.2. 
2.2.2.10 Sequencing of the plasmid DNA 
1 fig of plasmid DNA was sent to Invitrogen to perform sequencing with forward and 
reverse primers. The sequencing results were aligned with the original target sequence 
using the program BioEdit (Ibis Biosciences) to check if the sequence was correct. 
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Table 2.2. PCR reaction mixture (IX) 
Distilled water 39 |LI1 
lOX KOD buffer 5 
10 mM dNTPs 2 |LI1 
(2.5 mM each of dATP, dCTP, dGTP and dTTP) 
Forward primer (25 |iM) 1 |LI1 
Reverse primer (25 |iM) 1 fxl 
DNA Template 1 [i\ 
KOD DNA polymerase (5 U/ul) 1 |LI1 
Total 
Table 2.3. PCR cycles 
Temperature Time Number of cycles 
Initial denaturation 95 °C 5 min — 
Denaturation 95 °C 30 sec 
Thermal � 
Annealing 5 5 � C 30 sec 35 
cycle 
Elongation 72 C 1 min 
Final extension 72 10 min — 
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Table 2.4. Restriction enzyme digestion mixture 
pCIneo Vector Insert 
啦 0 12|li1 4 III 
Uncut vector / insert 5 |il 30 |il 
lOX EcoRIhuffQv (New England BioLabs Inc.) 2 i^l 4^1 
EcoRI(\0 U or 20 U , N e w England BioLabs Inc.) 0.5 |LI1 1 |LI1 
NotI(\Q U or 20 U, New England BioLabs Inc.) 0.5 |LI1 1 |il 
Total 2 M 407u 
Table 2.5. Ligation mixture 
1 OX T4 ligase buffer (New England BioLabs Inc.) 2 |LI1 
Linearized mini-pRSET vector 4 |LI1 
Digested DNA insert 13 jul 
丁4 DNA ligase (40 U/|LI1, New England BioLabs Inc.) 1 |LI1 
Total “ ^ ~ 
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Table 2.6. PGR reaction mixture for clone checking 
dH20 15.5 III 
lOX Reaction buffer 2 
lOmM dNTPs 1 jul 
(2.5 mM each ofdATP, dCTP, dGTP and dTTP) 
Forward primer (25 |LIM) 0.5 jil 
Reverse primer (25 jiM) 0.5 |il 
Taq DNA polymerase (5 U/ul) 0.5 )LI1 
Total ^ 
Table 2.7. PGR cycles for clone checking 
Temperature Time Number of cycles 
Initial denaturation 95 5 min — 
Denaturation 95 °C 30 sec 
Thermal 
Annealing 55 C 30 sec 35 
cycle 
Elongation 72 C 1 min 
Final extension 72 ""C 10 min — 
‘ ~ ^ 4 T : ^ 
51 
Table 2.8. Restriction digestion mixture for conformation of miniprep products 
dH20 14|il 
Miniprep products 4 |LI1 
lOX EcoRIhufiQX (New England BioLabs Inc.) 1 |LII 
EcoRI{\0 U or 20 U, New England BioLabs Inc.) 0.5 fil 
AW/(10 U or 20 U, New England BioLabs Inc.) 0.5 |il 
Total 
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2.2.3 Cell culture 
2.2.3.1 Cultivation of human lung epithelial NCI-H292 cells 
The human lung epithelial cell line NCI-H292 was purchased from American Type Culture 
Collection (ATCC, Manassas, VA, USA). RPMI 1640 (Invitrogen) supplement with 10% 
fetal bovine serum (FBS) (Life Technologies) was used to culture NCI-H292. Unless 
mentioned otherwise, the cells were growth in a 95% O2, 5% CO2 water saturated incubator 
at 37 Culture media were changed two times per week and the cells were sub-cultured 
whenever confluence was reached. During sub-cultivation, culture medium were first 
removed and discarded. Then 2 to 3 ml of Trypsin-EDTA solution was added to the flask. 
The cells were observed under an inverted microscope until cell layer was dispersed 
(usually within 5 to 15 min). Afterwards, 6 to 8 ml of complete growth medium was 
added and cells were aspirated by gently pipetting. Appropriate aliquots (usually in ratio 
1:3 to 1:8) of the cell suspension were added to new culture flasks and incubated in a 95% 
O2, 5% CO2 water saturated incubator at 37 
2.2.3.2 Transfection of cell culture 
Approximately 1 x 10^ NCI-H292 cells were transfected with 4 |Lig of empty plasmid 
(pCIneo), pCIneo-NSlA, pCIneo-NSlB or pCIneo-NSlC. Monolayers of NCI-H292 
cells prepared in 6-well plates were used for transfection. NCI-H292 cells were 
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transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's 
protocols. At 4 h and 24 h post-transfection, cells were collected. 
2.2.4 Western blot analysis 
2.2.4.1 Protein extraction 
Cells were collected at 4 h and 24 h post-transfection. The cells were resuspended and 
washed with ice-cold PBS for 3 times. The cell pellet was then resuspended in lysis 
buffer (2% SDS, 10% glycerol, 0.0625 M Tris/HCL, pH 8.0), and incubated on ice for 30 
min. After boiling for 10 min and centrifugating at 13000 g for 30 min at 4 the 
supernatant was collected for protein concentration determination before Western blot 
analysis. 
2.2.4.2 Determination of protein concentration 
Quantitation of protein samples was done by a modified Bradford method using reagents 
from the BioRad Protein Assay kit. Protein sample or standard protein was brought to 0.8 
ml by dH20. 0.2 ml of the dye reagent concentrate was added to each tube and mixed by 
vortex. The solution was incubated at room temperature for at least 5 min but not more 
than 1 h. OD595 was measured. 
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Standard curve was obtained by bringing 2, 4, 6, 8 and 10 |LI1 of BSA (1 mg/ml) to 0.8 ml by 
dHsO and adding 0.2 ml of the dye reagent concentrate. OD595 values of the standard 
proteins were plotted against protein content and a linear regression line was obtained. 
Concentration of protein sample was determined by fitting the OD595 value to the 
regression equation. 
2.2.4.3 Protein blotting 
Protein samples with equivalent concentrations were mixed with 6X protein loading dye to 
a final concentration of IX. They were heated for 5 min at 95 and were then resolved 
by 15% SDS-PAGE. Details of gel compositions are listed in Table 2.9. 25 fig of 
protein lysate was loaded to each lane. After electrophoresis, the stacking gel was 
discarded and the resolving gel was equilibrated in transfer buffer for 15 minutes or more. 
PVDF (Millipore) membrane and six pieces of Whatman 3-mm filter paper were cut to 
slightly larger size than the gel. The PVDF membrane was first rinsed briefly in analytic 
grade methanol and then equilibrated in transfer buffer for 15 min or more. The pieces of 
3-mm filter paper were attached into two stacks of three pieces and wetted with transfer 
buffer. 
Electroblotting was performed using a semi-dry electroblotter Trans-Blot Cell (BioRad). 
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Three pieces of wetted filter paper were placed onto the cathode and rolled over with a 1 ml 
pipette tip to expel air bubbles. The equilibrated membrane was placed on top of the filter 
paper. Then the gel equilibrated with transfer buffer was placed on top of the membrane, 
followed by a stack of three pieces of wetted filter paper. The sandwich was then rolled 
over with a 1 ml pipette tip to expel bubbles and excess buffer. Anode was then 
assembled to the blotter and constant voltage of 15 V was applied for 1 h. 
2.2.4.4 Membrane blocking and antibody incubations 
Electroblotted membrane was first blocked by 5% (w/v) not-fat milk in TBST at room 
temperature for 1 h. After washing with three changes of TBST each of 10 min, rabbit 
anti-NSlA, anti-NSlB or anti-NSlC antibodies in a dilution 1:2000 diluted with TBST was 
applied to the membrane and incubated at 4 � C overnight with continuous shaking. The 
membrane was then washed with three changes of TBST each of 10 min. Anti-rabbit IgG 
conjugated with horseradish peroxidase (HRP) (Amersham Pharmacia, Uppsala, Sweden) 
was diluted in TBST in a concentration suggested by manufacturer and incubated with the 
membrane at room temperature for 1 h, followed by washing with three changes of TBST 
each of 10 min. 
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2.2.4.5 Detection of proteins 
Enhanced chemiluminance (ECL) kit (Amersham Pharmacia Biotech.) was used. 0.5 ml 
of solution A and 0.5 ml of solution B were mixed just prior to application and was applied 
to the membrane and incubated at room temperature for 2 min. The solution mix was then 
stripped off by placing the membrane over a paper towel and then wrapped by a plastic 
wrap over a thin plastic plate. The membrane was then exposed to a Kodak BioMax MR 
film at certain time intervals (usually 10 s to 20 min). The film was then developed by 
soaking in developing solution, followed by fixation solution. 
Table 2.9. Details for resolving (15%) and stacking (5%) SDS-PAGE gel 
Resolving Gel (15%) Stacking Gel (5%) 
dFbO 1.7 ml dFbO 2.7 ml 
30% acrylamide solution 3.75 ml 30% acrylamide solution 0.67 ml 
1.5 MTris (pH 8.8) 1.9 ml l .SMTr i s (pH 6.8) 0.5 ml 
10% SDS 75 111 10% SDS 40 |li1 
APS 75 |Ld APS 40 jid 
TEMED 3 |il TEMED 4 |LI1 
Total � 7 . 5 ml Total � 4 ml 
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2.2.5 Total RNA extraction 
2.2.5.1 Preparation of cell culture for total RNA extraction 
1 ml of TRIzol reagent (Invitrogen) was added to each well of the 6-well plate containing 
monolayer of NCI-H292 cells. Total RNA samples were extracted from NCI-H292 cells 
using TRIzol reagent (Invitrogen) according to the manufacturer's protocols. Quantity, 
purity and integrity of the total RNA extracted were checked before the experiment. 
2.2.5.2 Spectrophotometric analysis of total RNA 
The quantity and purity of RNA were determined by optical density measurement. 
Quantification of RNA was done by measuring absorbance of RNA samples at 260 nm. 1 
OD unit at 260 nm corresponds to 40 |ig/ml of RNA. RNA concentration was estimated 
by applying the Beer's Law 'A = cbc', where: 
A: Absorbance 
s : Molar absorptivity (LmoT'cm'') 
b: Path length of sample (cm) 
c: Concentration of compound in solution (molL—i) 
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Purity of RNA was determined by OD260/OD280 ratio. This ratio was determined by 
measuring absorbance of RNA samples at 260 nm and 280 nm. The RNA samples were 
considered to be pure when the OD260/OD280 ratio was higher than 1.8. 
2.2.5.3 Agarose gel electrophoresis of total RNA 
The integrity of RNA extract was determined by electrophoresis in 1.5% agarose gel with 
ethidium bromide staining. 1.5 % (w/v) agarose gel was prepared by dissolving 0.45 g of 
agarose powder in 30 ml of IX TAE buffer, with 1 |il of ethidium bromide (10 mg/ml) 
added. RNA samples were mixed with 6X DNA loading buffer to give a final 
concentration of IX. The gel was submerged into a gel tank containing fresh IX TAE 
buffer. After loading the samples and Gene Ruler™ DNA Ladder Mix (Invitrogen, USA) 
into the wells, electrophoresis was performed with a constant voltage of 100 V. The 
agarose gel was then placed onto a Spectroline TC-302 transilluminator (302 nm) for 
visualization of RNA. 
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2.2.6 DNA Microarray 
2.2.6.1 Preparation of biotin-labeled antisense cRNA 
01igo(dT)-primed cDNA were synthesized from total RNA using SuperScript kit 
(Invitrogen) according to the manufacturer's protocols. After second-strand synthesis, 
biotinylated RNA were produced by in vitro transcription using biotinylated UTP and CTP 
(Bioarray high-yield RNA transcript labeling kit, Enzo Diagnostics), and purified with 
RNeasy mini columns (Qiagen) according to the manufacturer's protocols. The 
biotinylated RNA were chemically fragmented by heating in MgOAc/KOAc buffer to 
produce fragments of 35-200 bases. 
2.2.6.2 Hybridization, washing and scanning of DNA microarray chips 
The fragmented RNA was hybridized to GeneChip Human Genome U133 Plus 2.0 Array 
(Affymetrix) for 16 h at 45°C. The chip was then washed with non-stringent wash buffer 
(6X SSPE, 0.01% (v/v) Tween-20) and subsequently stringent washing buffer (100 mM 
MES, O.IM NaCl, 0.01% (v/v) Tween-20). After that, the chip was stained with a 
streptavidin-phycoerythrin (SAFE) conjugate (Molecular Probes) and visualized with 
ScanArray 4000 (Packard Bioscience). 
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2.2.6.3 Data Processing and analysis 
Gene probes not expressed in any of the samples {P = 0.05) were considered absent, and 
were removed from the dataset and not included in further analyses. Probes not having a 
significant difference (P = 0.0001) were removed from the dataset. Signal values were 
normalized by subtracting the mean of a probe across all arrays from its value on each array, 
and dividing the difference by the standard deviation of values for that gene. Empty 
plasmid-transfected cells and NSl-transfected cells were used as calibrator and sample 
respectively to calculate the relative fold changes. Differentially expressed genes with 
more than 2-fold changes were selected for further analyses. Hierarchical clustering 
analysis was performed using Cluster software (Eisen et al., 1998) Hierarchical Clustering 
Explorer 3.0 (HCE) publicly available at http://www.cs.umd.edu/hcil/hce. Differentially 
expressed genes with more than 2-fold changes were categorized by the Panther 
classification database publicly available at http://www.pantherdb.org. To provide more 
sets of data for statistical analysis, two individual experiments were performed for NSIA. 
The perturbation of selected genes were confirmed and quantified by QRT-PCR. 
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2.2.7 Quantitative real-time PCR (ORT-PCR) 
2.2.7.1 Preparation of cDNA 
01igo(dT)-primed cDNA were synthesized from total RNA using SuperScript kit 
(Invitrogen) according to the manufacturer's protocols. 
2.2.7.2 Analysis of mRNA gene expression by QRT-PCR 
The amounts of respective cytokine mRNA transcripts were quantified using QRT-PCR. 
The oligo(dT)-primed cDNA products of reverse transcription were used for each PCR. 
PCR were performed in a mixture containing target cytokine gene-specific primers and 
Power SYBR green PCR master mix (Applied Biosystems) according to the manufacturer's 
protocols. The data were analyzed using the function where AACT = (CT, 
Target - CT, P-act in)sampie — (CT, Target - CT, P-actin)caiibrator (Johnson et al., 2000). 
3-actin was used as an internal control to normalize PCR for the amount of RNA added to 
the reactions. We used non-transfected cells as a calibrator while empty plasmid- or 
NSl-transfected cells as a sample to indicate the relative difference. To provide multiple 




Roles of NSIA and NSIB on cellular gene expression 
3.1 Introduction 
Upon viral infection, viral single-stranded and double-stranded RNAs with phosphorylated 
5' ends are produced. These viral RNA molecules activate multiple cellular signaling 
pathways, resulting in activation and movement of transcription factors such as IRFs, 
N F - K B and c - Jun /ATF2 (Iwamura et al., 2 0 0 1 ; Sato et al., 2 0 0 0 ; Servant et al., 2 0 0 2 ) from 
cytoplasm into nucleus to initiate type I I FN expression. The binding of IFN-a/p subtypes 
to its receptor activates JAK-STAT signaling pathway, resulting in expression of 
IFN-stimulated genes (De Veer et al., 2001; Samuel et al., 2001) such as Mx G丁Pases 
(Haller et al., 2002), PKR (Bergmann et al., 2000; Hatada et al., 1999) and genes in 
OAS/RNase L system (Min et al,, 2006). These trigger the host immune responses to 
clear the viruses and to stop the viral replication. In addition to IFNs, secretion of other 
cytokines and chemokines important in the inflammatory responses also plays significant 
roles in host defense. They are able to augment immune regulation and contain infection 
(Taylor et al., 2005; Twigg, 2004). To antagonize the efficient and effective host antiviral 63 
responses, viruses have evolved different mechanism (Garcia-Sastre et al., 2006; Haller et 
aL, 2006). Among the influenza viral proteins, NSl is the most important viral regulatory 
factor during infection and is the best-studied example of viral I FN antagonists 
(Garcia-Sastre et al., 2001). 
NSl is a multifunctional protein. It has been shown to regulate a variety of host cell 
function in multiple levels to facilitate viral survival and replication in host cells. In 
post-transcriptional level, by blocking nuclear export of polyadenylated cellular transcripts 
(Fortes et aL, 1994; Qiu et al., 1994; Satterly et al., 2007), NSl inhibits host cell mRNA 
processing (Lu et al., 1994). In translational level, by forming a trimeric complex with 
eukaryotic translation initiation factor eIF4GI and poly(A)-binding protein I (PABI), it 
enhances the initiation of translation of viral mRNAs (Burgui et al., 2003). In protein 
level, through its N-terminal RBD, it binds and sequesters dsRNA away from host antiviral 
protein (Donelan et al., 2003; Wang et aL, 1999). The sequestration of RNA prevents 
activation of the transcription factors I R F 3 , I R F 7 , N F - K B , and c - J u n / A T F 2 , and thus 
prevents activation of OAS/RNase L system (Min et al., 2006), N F - K B signaling pathway 
and other antiviral signaling pathways. Being able to sequestrate small interfering RNA 
(Bucher et al., 2004; Li et aL, 2004), NSl can also suppress induction of RNA interference. 
Apart from that, through binding to PKR, which regulates host protein synthesis, and 
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phosphatidylinositol 3-kinase (PI3K), NSl regulates their activation and has a direct 
enhancing effect on viral replication (Hale et aL, 2006; Li et al., 2006). In addition, NSl 
proteins of some virus strains have been shown to suppress the antiviral function of IFNs 
and TNF-a (Geiss et al., 2002; Hayman et al., 2006; Seo et al., 2002). 
NSl A and NSIB differ markedly both in amino acid sequences and function. NSl A and 
NSIB have less than 20% sequence identity and fulfill different functions. Both NSl A 
and NSIB bind dsRNA via their N-terminal RBDs (Wang & Krug, 1996) and can act as 
I FN antagonists and inhibit the IFN-inducible PKR (Dauber et al., 2004). Besides these 
similar roles, others differ markedly. In contrast to NSl A, NSIB is not able to induce 
PI3K signaling, which prevents premature apoptosis during viral propagation (Ehrhardt et 
al., 2007), and is not able to inhibit polyadenylation, splicing, and nuclear export of cellular 
mRNA (Wang & Krug, 1996), but it has the distinctive ability of binding to ISGl 5 protein, 
an anti-viral protein, and to inhibit its conjugation to cellular targets (Yuan et al., 2001; 
Yuan et al., 2002). 
How NSl protein functions in the host cells is critical in viral pathogenesis. The degree of 
virulence may depend on the sequence of the gene encoding the NSl protein. More 
pathogenic influenza virus subtypes like influenza A H5N1 may have an NSl gene with 
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stronger ability to antagonize host cell antiviral responses. We expect that NSIA and 
NSIB proteins, having distinct amino acid sequences, might induce different host cell gene 
expression patterns to adopt different strategies to antagonize the host defense. The 
different cellular gene expression due to the NSIA and NSIB proteins may explain the 
distinct pathologies and disease severity of influenza A and B viruses. In this chapter, 
with microarray technologies using GeneChip Human Genome U133 Plus 2.0 Arrays 
(Affymetrix), which allowed us to perform large-scale gene expression studies, we 
identified different gene expression profiles triggered by NSIA and NSIB proteins in 
human lung epithelial cells NCI-H292. By comparing the gene expression profiles, we 
could understand more about the action of NSIA and NSIB proteins on host cells, and 
might explain the virulence and pathogenesis of influenza A viruses. These findings will 
lay the foundation to select for new antiviral compounds against influenza virus and the 
development of new generation of safe and immunogenic NSl-based live influenza virus 
vaccines in the future. 
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3.2 Results 
3.2.1 NSl protein expression in transfected NCI-H292 cells 
Human lung epithelial cell line NCI-H292 was transfected with empty plasmid or plasmid 
containing NSl genes from influenza A/Hong Kong/156/97(H5Nl) or influenza B/Hong 
Kong/692/01. At 4 h and 24 h post-transfection, cells were collected. Expression of 
N S I A and N S I B proteins were confirmed by Western blots. No NSl protein expression 
was detected in non-transfected cells or cells transfected with empty plasmid in both time 
points (Figure 3.1). 
3.2.2 Purity and integrity of total RNA extracted 
Total RNA samples were extracted from transfected NCI-H292 cells at 24 h 
post-transfection using TRIzol reagent (Invitrogen) according to the manufacturer's 
protocols. RNA integrity was determined by electrophoresis with 1.5% agarose gel with 
ethidium bromide staining. RNA extracted from pCIneo-, pCIneo-NSl A- and 
pCIneo-NSlB-transfected NCI-H292 cells showed high integrity (Figure 3.2). Apart from 
that, purity of RNA was determined by optical density measurement by measuring the 
OD260/OD280 ratios. The OD260/OD280 ratios for total RNA extracted from pCIneo-, 
pCIneo-NSlA- and pCIneo-NSlB-transfected NCI-H292 cells were 1.89，1.92 and 1.95 
respectively, showing that the purity of the RNA extracts were within the acceptable range. 
67 
4 h 24 h post - t ransfect ion 
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Figure 3.1. Expression of NSl proteins in NSl-transfected NCI-H292 cells. 
Western blot analyses were performed on the protein lysates of pCIneo-transfected, 
pClneo-NS 1 -transfected or non-transfected NCI-H292 cells. Equal amount of protein 
lysate was loaded to each lane. NSIA and NSIB proteins were detected by anti-NSlA 
and anti-NSlB rabbit antibodies as single protein band with sizes of about 26 and 31 kDa 
respectively. Whole cell lysates were prepared from: (A) non-transfected control cells, (B) 
empty plasmid (pCIneo)-transfected cells, (C) pCIneo-NS 1 A-transfected cells and (D) 
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Figure 3.2. Determination of integrity of total RNA extracted. Integrity of the total 
RNA extracted was confirmed by electrophoresis in 1.5% agarose gel with ethidium 
bromide staining before further experiments. Lanes 1, 2 and 3 show the total RNA 
extracted from pCIneo-, pCIneo-NSlA- and pCIneo-NS 1 B-transfected NCI-H292 cells 
respectively. All of the total RNA extracts showed high integrity. 
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3.2.3 Microarray data processing and analysis 
NCI-H292 cells were transfected with empty plasmid or plasmid containing NSl genes 
from influenza A/Hong Kong/156/97(H5Nl) or influenza B/Hong Kong/692/01. At 24 h 
post-transfection, total RNA was extracted and sent to the Gene Company (Hong Kong) for 
DNA microarray analyses. Global cellular gene expression in cells transfected with NSl 
were examined and compared. Empty plasmid transfected cells and NSl-transfected cells 
were used as calibrator and sample respectively to calculate the relative fold changes. 
Differentially expressed genes with more than 2-fold changes in expression level and with 
greater than 99% confidence {P < 0.01) were selected. The fold change presented was the 
mean of two independent replicates. Two housekeeping genes p-actin and glyceraldehyde 
3-phosphate dehydrogenase (GAPDH) were chosen as internal controls. The gene 
expression of P-actin and GAPDH was unaffected by NSIA and NSIB protein expression. 
100 genes were perturbed by NSIA protein, in which 68 genes were down-regulated (Table 
3.1 and 3.2). 72 genes were perturbed by NSIB protein, in which 51 genes were 
down-regulated (Table 3.3 and 3.4). The differentially expressed genes selected were 
grouped into three groups for further analyses: (1) genes perturbed by both NSIA and 
NSIB proteins, (2) genes perturbed only by NSIA protein and (3) genes perturbed only by 
NSIB protein, as summarized in Figure 3.3 and 3.4. 
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Figure 3.3. Schematic diagram of number of genes affected by NSIA and NSIB 
proteins. Genes with more than 2-fold changes in expression level and with greater than 
99% confidence (P < 0.01) were selected. The black area represents the number of genes 
affected by NSIA protein only, the white area represents the number of genes affected by 
NSIB protein only, and the grey area represents the number of genes commonly affected 
by both NSIA and N S I B proteins. 100 genes were affected by NSIA protein and 72 
genes were affected by NSIB protein. 48 genes were commonly affected by both NSIA 
and NSIB proteins. 
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Figure 3.4. Summary of cellular genes perturbed by NSIA and NSIB. Genes with 
more than 2-fold changes in expression level and with greater than 99% confidence {P < 
0.01) were selected. Green indicates that expression was repressed by N S l , and red 
indicates that expression was induced by N S l . The shade of green and red represents the 
degree of change. The scale represents logio ratios. * indicates IFN-stimulated genes, # 
indicates potential antiviral genes, and ^ indicates cytokines and chemokines. The cellular 
genes represented in each panel are: (A) genes commonly regulated by N S I A and NSIB, 
(B) genes regulated by N S I A only, and (C) genes regulated by N S I B only. 
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Table 3.2. List of genes down-regulated by NSIA. 
Gene Gene Name Fold Change Fold Change Average 
Symbol Found in Found in Fold 
Experiment 1 Experiment 2 Change 
ACY1L2 Aminoacylase 1-like 2 + 2 ^ +Z0 
ANXAl AnnexinAl +4^0 + 4 ^ + 4 3 
BCATl Branched chain +4^0 
aminotransferase 1, cytosolic 
BCL2 B-cell CLL/lymphoma 2 
CRTC3 CREB regulated + 4 ^ 
transcription coactivator 3 
CUL2 Cullin2 
DLX2 Distal-less homeo box 2 +13.0 +10.2 
D0CK9 Dedicator of cytokinesis 9 +2.0 
FAM63B Family with sequence +2.0 +2.8 +2.4 
similarity 63, member B 
GALM Galactose mutarotase (aldose +4.0 +4.3 +4.1 
1-epimerase) 
GPAM Glycerol-3-phosphate +4.0 +2.3 +3.0 
acyltransferase 
GUSBPl Glucuronidase, beta 
pseudogene 1 
HIST1H3H Histone cluster 1, H3h +4.0 +2.1 +2.9 
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HS2ST1 Heparan sulfate +Z5 
2-0-sulfotransferase 1 
HSPDl Heat shock 60kDa protein 1 + 4 0 
(chaperonin) 
ILIO Interleukin 10 
L O C 2 8 6 4 6 7 H y p o t h e t i c a l protein ^ ^ + 2 ^ 
L O C 3 7 5 0 1 0 H y p o t h e t i c a l protein + 4 ^ 
NFYB Nuclear transcription factor +4.0 +2.5 +3.1 
Y, beta 
OFDl Oral-facial-digital syndrome + 4 ^ +2.1 +2.9 
1 
PRKAAl Protein kinase, +4^0 +2.8 
AMP-activated, alpha 1 
catalytic subunit 
RFXDC2 Regulatory factor X domain +3.7 +2.1 +2.8 
containing 2 
SGMS2 Sphingomyelin synthase 2 +4.0 +2.0 +2.8 
SOCSl Suppressor of cytokine +4.6 +4.3 +4.4 
signaling 1 
S0CS3 Suppressor of cytokine +2.1 +4.0 +3.1 
signaling 3 
Spl transcription factor +2.8 +2.0 +2.4 
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UBLCPl Ubiquitin-like domain + 4 ^ " 1 + l 9 
containing CTD phosphatase 
1 
WDR37 WD repeat domain 37 + 0 + 7 ^ + 7 ^ 
YTHDCl YTH domain containing 1 + 4 ^ 
ZBTB26 Zinc finger and BTB domain + 4 ^ 
containing 26 
Z C 3 H A V 1 L Z i n c finger CCCH-type, + 4 ^ + 4 0 + 4 ^ 
antiviral 1-like 
ZNF654 Zinc finger protein 654 + 4 0 +3.1 
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Table 3.2. List of genes down-regulated by NSIA. 
Gene Gene Name Fold Change Fold Change Average 
Symbol Found in Found in Fold 
Experiment 1 Experiment 2 Change 
ATP-binding cassette, 
ABCBl l -4.0 -6.5 -5.1 
sub-family B, member 11 
ATP-binding cassette, 
ABCB5 -4.6 -6.3 -5.5 
sub-family B, member 5 
ATP-binding cassette, 
ABCB9 -5.7 -7.0 -6.3 
sub-family B, member 9 
ATPase, Ca++ transporting, 
ATP2B2 -4.0 -3.7 -3.9 
plasma membrane 2 
Caspase 3, apoptosis-related 
CASP3 -3.0 -3.7 -3.4 
cysteine peptidase 
Chemokine (C-C motif) 
CCL5 -4.0 -2.1 -2.9 
ligand 5 
Carcinoembryonic 
CEACAM3 antigen-related cell adhesion -2.0 -2.3 -2.1 
molecule 3 
Carcinoembryonic 
antigen-related cell adhesion 




CEACAM8 antigen-related cell adhesion -2.0 -8.0 -4.0 
molecule 8 
Cbp/p300-interacting 
CITED2 -2.1 -3.7 -2.8 
transactivator 2 
cAMP responsive element 
CREB5 -8.0 -14.9 -10.9 
binding protein 5 
Chemokine (C-X-C motif) 
CXCLIO -3.0 -2.1 -2.5 
ligand 10 
Chemokine (C-X-C motif) 
CXCLl l -4.0 -2.1 -2.9 
ligand 11 
Chemokine (C-X-C motif) 
CXCL12 -2.0 -2.8 -2.4 
ligand 12 
Chemokine (C-X-C motif) 
CXCR4 -2.1 -7.5 -4.0 
receptor 4 
Chemokine (C-X-C motif) 
CXCR6 -4.0 -2.5 -3.1 
receptor 6 
Chemokine (C-X-C motif) 
CXCR7 -4.0 -2.1 -2.9 
receptor 7 
Guanylate binding protein 1, 
GBPl -3.0 -2.0 -2.5 
interferon-inducible, 67kDa 
GBP4 Guanylate binding protein 4 -4.0 -4.0 -4.0 
GBP5 Guanylate binding protein 5 -4.0 ^ ^ 
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GBP6 Guanylate binding protein 6 -4.0 -4.0 -4.0 
Hypoxia inducible factor 3, 
HIF3A -3.0 -2.0 -2.5 
alpha subunit 
Interferon, gamma-inducible 
IFI16 -4.0 -2.1 -2.9 
protein 16 
IFNA13 Interferon, alpha 13 ^ ^ ^ 
IFNA16 Interferon, alpha 16 -13.9 ^ -10.9 
IFNA17 Interferon, alpha 17 ^ ^ -3.0 
IFNA6 Interferon, alpha 6 ^ ^ ^ 
IFNBl Interferon, beta 1 ^ ^ ^ 
IL15RA Interleukin 15 receptor, alpha -2.0 -2.0 -2.0 
IL18 Interleukin 18 ^ ^ 
Interleukin 18 receptor 
IL18RAP -1.0 -8.6 -2.9 
accessory protein 
ILIB Interleukin 1, beta ^ ^ ^ 
1L28 Interleukin 28 ^ ^ ^ 
IL29 Interleukin 29 ^ ^ ^ 
1 1 6 Interleukin 6 -4.3 -5.3 -4.8 
IL7R Interleukin 7 receptor -2.8 -4.0 -3.4 
Interleukin 8 ^ ^ ^ 
IRFl Interferon regulatory factor 1 -4.0 -4.0 -4.0 
IRF4 Interferon regulatory factor 4 -3.5 -3.2 -3.4 
IRF7 Interferon regulatory factor 7 -3.2 -2.3 -2.7 
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Interferon-stimulated 
ISGF3 transcription factor 3, gamma -2.5 -2.6 -2.5 
48kDa 
Lysosomal-associated 
LAMP2 -2.6 -2.0 -2.3 
membrane protein 2 
Lectin, galactoside-binding, 
LGALS4 -4.0 -4.9 -4.4 
soluble, 4 (galectin 4) 
Lectin, galactoside-binding, 
LGALS7 -4.9 -4.0 -4.4 
soluble, 7 (galectin 7) 
Lectin, galactoside-binding, 
LGALS9 -4.9 -4.0 -4.4 
soluble, 9 (galectin 9) 
LMAN2 Lectin, mannose-binding 2 -12.0 -7.9 -9.8 
Mitogen-activated protein 
MAP4K4 -2.8 -4.0 -3.4 
kinase kinase kinase kinase 4 
Myxovirus (influenza virus) 
MXl -4.0 -3.2 -3.6 
resistance 1 
Myxovirus (influenza virus) 
MX2 -2.0 -4.3 -2.9 
resistance 2 
Myeloid differentiation 
MYD88 -2.0 -3.7 -2.7 
primary response gene (88) 
NMI . N-myc (and STAT) interactor -2.3 -6,1 -3.7 
2,, 5'-oligoadenylate 
OASl -4.0 -5.3 -4.6 
synthetase 1, 40/46kDa 
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RAIl Retinoic acid induced 1 ^ ^ T ^ ^ 
RPLIO Ribosomal protein LIO ^ ^ ^ 
Signal transducer and 
STATl -4.9 -4.0 -4.4 
activator of transcription 1 
Signal transducer and 
STAT2 -5.3 -4.0 -4.6 
activator of transcription 2 
Signal transducer and 
STAT3 -4.3 -2.0 -2.9 
activator of transcription 3 
Signal transducer and 
STAT4 -4.0 -2.6 -3.2 
activator of transcription 4 
STK32A Serine/threonine kinase 32A ^ -21.1 -13.0 
Transcription elongation 
TCEB3B -4.0 -2.1 -2.9 
factor B polypeptide 3B 
TMEM53 Transmembrane protein 53 -2.0 -2.3 -2.1 
Tumor necrosis factor (TNF 
TNF -4.0 -9.2 -6.1 
superfamily, member 2) 
Tumor necrosis factor, 
TNFAIP2 -2.6 -2.1 -2.4 
alpha-induced protein 2 
Tumor necrosis factor 
TNFSFIO -4.0 -4.0 -4.0 
superfamily, member 10 
Tumor necrosis factor 
TNFSF13B (ligand) superfamily, -3.5 -4.0 -3.7 
member 13b 
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Tumor necrosis factor 
TNFSF14 (ligand) superfamily, -4.3 -2.3 -3.1 
member 14 
Tumor necrosis factor 
TNFSF18 (ligand) superfamily, -4.3 -6.1 -5.1 
member 18 
Tumor necrosis factor 
TNFSF9 (ligand) superfamily, -4.0 -2.1 -2.9 
member 9 
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Table 3.2. List of genes down-regulated by NSIA. 
Gene Gene Name Fold Change Fold Change Average 
Symbol Found in Found in Fold 
Experiment 1 Experiment 2 Change 
ACY1L2 Aminoacylase 1-like 2 + Z 4 ^ 
1 -acylglycerol-3-phosphate 
AGPAT5 +2.6 +3.5 +3.1 
0-acyltransferase 5 
Aldehyde dehydrogenase 1 
ALDH1A3 +2.1 +2.0 +2.1 
family, member A3 
ATP 13A3 ATPase type 13A3 ^ 
Branched chain 
BCATl +2.5 +4.0 +3.2 
aminotransferase 1, cytosolic 
CUL2 Cull in2 +4.0 
Glycerol-3-phosphate 
GPAM +2.8 +2.5 +2.6 
acyltransferase, mitochondrial 
HECTDl HECT domain containing 1 
Histidine acid phosphatase 
HISPPDl +2.3 +2.8 +2.6 
domain containing 1 
Heparan sulfate 
HS2ST1 +2.0 +4.0 +3.0 
2-0-sulfotransferase 1 
Heat shock 60kDa protein 1 
HSPDl +2.6 +2.8 +2.7 
(chaperonin) 
Hypothetical protein 
KIAA1715 +2.3 +2.5 +2.4 
KIAA1715 
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Keratin associated protein 
KRTAP4-10 +3.7 +4.0 +3.9 
4-10 
Myosin VA (heavy chain 12, 
M Y 0 5 A +2.3 +3.2 +2.8 
myoxin) 
NLR family, apoptosis 
NAIP +2.1 +2.6 +2.4 
inhibitory protein 
NF of activated T-cells, 
NFATC2IP calcineurin 2 interacting +2.0 +2.6 +2.3 
protein 
Proteasome (prosome, 
PSMC2 macropain) 26S subunit, +2.0 +4.9 +3.5 
ATPase, 2 
Rrotein tyrosine phosphatase, 
PTPRG +2.1 +4.6 +3.4 
receptor type, G 
SGMS2 Sphingomyelin synthase 2 
WRB Tryptophan rich basic protein +2.0 +2.3 +2.1 
ZNF257 Zinc finger protein 257 +10.6 
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Table 3.2. List of genes down-regulated by NSIA. 
Gene Gene Name Fold Change Fold Change Average 
Symbol Found in Found in Fold 
Experiment 1 Experiment 2 Change 
ATP-binding cassette, 
ABCBl l -4.9 -3.5 -4.2 
sub-family B, member 11 
ATP-binding cassette, 
ABCB5 -3.7 -4.3 -4.0 
sub-family B, member 5 
Angiotensin I converting 
ACE2 enzyme -3.2 -4.0 -3.6 
(peptidyl-dipeptidase A) 2 
Activating transcription 
ATF3 -7.0 -6.1 -6.5 
factor 3 
CCL5 Chemokine ligand 5 ^ -4.3 -4.3 
Carcinoembryonic 
CEACAMl antigen-related cell adhesion -2.3 -2.6 -2.5 
molecule 1 
Carcinoembryonic 
CEACAM21 antigen-related cell adhesion -2.1 -2.6 -2A 
molecule 21 
Carcinoembryonic 




CEACAM6 antigen-related cell adhesion -2.6 -5.3 -4.0 
molecule 6 
Carcinoembryonic 
CEACAM7 antigen-related cell adhesion -4.3 -3.5 -3.9 
molecule 7 
Carcinoembryonic 
CEACAM8 antigen-related cell adhesion -2.6 -5.7 -4.1 
molecule 8 
Cofactor required for Spl 
CRSP3 transcription activation, -13.0 -8.0 -10.5 
subunit 3 
Chemokine (C-X-C motif) 
CXCLIO -2.8 -3.2 -3.0 
ligand 10 
Chemokine (C-X-C motif) 
CXCLll -3.2 -3.2 -3.2 
ligand 11 
Chemokine (C-X-C motif) 
CXCR4 -5.7 -4.0 -4.8 
receptor 4 
Chemokine (C-X-C motif) 
CXCR6 -8.6 -8.0 -8.3 
receptor 6 
F G F 2 F b r o b l a s t growth factor 2 -2.5 -2.3 -2.4 
GBPl Guanylate binding protein 1 -2.0 -2.5 -2.2 
GBP4 Guanylate binding protein 4 -2.0 -3.5 -2.7 
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GBP5 Guanylate binding protein 5 -5.7 -2.0 -3.8 
GBP6 Guanylate binding protein 6 -2.3 -7.5 -4.9 
G protein-coupled receptor 
GPR109B -2.8 -2.6 -2.7 
109B 
Hypoxia inducible factor 3, 
HIF3A -10.6 -8.6 -9.6 
alpha subunit 
Interferon, gamma-inducible 
IFI16 -24.3 -16.0 -20.1 
protein 16 
IFNA13 Interferon, alpha 13 ^ ^ 
IFNA16 Interferon, alpha 16 ^ T ^ ^To^ 
IFNA17 Interferon, alpha 17 ^ -2.8 -2.4 
IFNA6 Interferon, alpha 6 -2.0 -3.7 -2.9 
IFNBl Interferon, beta 1 -6.0 -8.0 -7.0 
IL15RA Interleukin 15 receptor, alpha -2.0 -4.6 -3.3 
IL18 Interleukin 18 ^ T s ^ 
interleukin 18 receptor 
IL18RAP -7.5 -3.7 -5.6 
accessory protein 
ILIB Interleukin 1, beta -3.5 -4.5 -4.0 
1 l 2 8 Interleukin 28 ^ ^ h 
IL29 Interleukin 29 ^ -4.6 -4.9 
l l ^ . Interleukin 6 ^ -5.0 -4.0 
IL7R ilnterleukin 7 receptor -2.0 -2.1 -2.1 
1 l 8 Interleukin 8 ^ ^ ^ 
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IRF4 Interferon regulatory factor 4 -4.6 -4.6 -4.6 
ISG15 Interferon stimulated gene 15 ^ ^ ^ 
ISG20 Interferon stimulated gene 15 -3.0 -5.7 -4.3 
mitogen-activated protein 
MAP4K4 -2.3 -3.7 -3.0 
kinase kinase kinase kinase 4 
2 ' , 5'-oligoadenylate 
OASl -3.2 -0.2 -1.7 
synthetase 1, 40/46kDa 
RAIl Retinoic acid induced 1 -7.0 -5.7 -6.3 
Tumor necrosis factor (TNF 
TNF -3.1 -3.3 -3.2 
superfamily, member 2) 
Tumor necrosis factor, 
TNFAIP2 -2.6 -6.1 -4.4 
alpha-induced protein 2 
Tumor necrosis factor 
TNFSFIO -2.8 -3.7 -3.3 
superfamily, member 10 
Tumor necrosis factor 
TNFSF13B -4.0 -3.7 -3.9 
superfamily, member 13b 
Tumor necrosis factor 
TNFSF14 -2.6 -3.0 -2.8 
superfamily, member 14 
Tumor necrosis factor 
TNFSF18 -2.6 -3.7 -3.2 
superfamily, member 18 
Tumor necrosis factor 
TNFSF9 -2.6 -3.2 -2.9 
superfamily, member 9 
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3.2.3.1 Genes perturbed by NSIA 
100 genes were perturbed by NSIA. These 100 genes were classified for the molecular 
function, biological process and signaling pathway using the Panther database publicly 
available at http://www.pantherdb.org. Among the molecular function groups, many hits 
are in the 'transcription factor' (16.5%) and 'signaling molecule' (15.4%). Among the 
biological process groups, many hits are in the 'immunity and defense' (18.8%) and 'signal 
transduction' (16.0%) genes. Among the signaling pathway groups, many hits are in the 
'inflammation mediated by chemokine and cytokine signaling' (16.9%), ‘interleukin 
signaling pathway' (12.9%) and ‘JAK/STAT signaling，(8.1%). 
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(A) 
K t e ^ A A wLm B I s o m e r a s e ( 0 . 8 % ) 
N S 1 A M o l e c u l a r F u n c t i o n 因 Miscellaneous function (2 4。/。） 
B T r a n s f e r a s e ( 3 . 9 % ) 
i B E S " - ^ • T rans fe r / ca r r i e r p ro te i n ( 0 . 8 % ) 
\ H l o n c h a n n e l ( 1 . 6 % ) 
\ \ B T r a n s p o r t e r ( 3 . 5 % ) 
/ \ \ IS S y n t h a s e a n d s y n t h e t a s e ( 0 . 8 % ) 
/ \ \ m • D e f e n s e / i m m u n i t y p r o t e i n ( 0 . 8 % ) 
/ \ \ \ • T r a n s c r i p t i o n f a c t o r ( 1 6 . 5 % ) 
/ \ \ I j ^ j ^ P ^ \ • Hydrolase (3.5%) 
• M o l e c u l a r f u n c t i o n u n c l a s s i f i e d ( 1 3 . 0 % ) 
B R e c e p t o r ( 2 . 8 % ) 
口 S e l e c t r egu la to r y m o l e c u l e ( 7 . 1 % ) 
B M e m b r a n e traf f ic p r o t e i n ( 1 . 6 % ) 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ B C y t o s k e l e t a l p ro te i n ( 1 . 6 % ) 
7 0 S e l e c t c a l c i u m b i n d i n g p ro te i n ( 0 . 8 % ) 
^ H v I ^ F ； ^ ^ ^ ^ ^ ^ ^ ^ ^ 画 Signaling molecule (15.4%) 
NCTT^ J ^ ^ ^ ^ ^ ^ • Chaperone (0.8%) 
• N u c l e i c . a c i d b i nd ing ( 1 3 . 8 % ) 
• Ce l l a d h e s i o n m o l e c u l e ( 5 . 5 % ) 
• K i n a s e ( 2 . 4 % ) 
(B) 
• S i g n a l t r a n s d u c t i o n ( 1 6 . 0 % ) 
NS1A Biological P r o c e s s • suifur metabolism (0.5%) 
B D e v e l o p m e n t a l p r o c e s s e s ( 4 . 5 % ) 
• O t h e r m e t a b o l i s m ( 1 . 5 % ) 
n C e l l p ro l i fe ra t ion a n d d i f f e ren t i a t i on ( 3 . 0 % ) 
• Ce l l s t r u c t u r e a n d mo t i l i t y ( 5 . 0 % ) 
jj&'^^A \ B Immunity and defense (18.8%) 
匪 Apoptosis (9.0。/。） 
^^^^：^：：;；^]!^ !^^^ H O n c o g e n e s i s ( 3 . 3 % ) 
口 T•一 (3.3%) 
！I P h o s p h a t e m e t a b o l i s m ( 0 . 5 % ) 
‘ • C a r b o h y d r a t e m e t a b o l i s m ( 1 . 8 % ) 
^ . - ^ ^ ^ ^ •BfciPlRfew. 口 Homeostasis (1.0%) 
y b N u c l e o s i d e , n u c l e o t i d e a n d n u c l e i c a c i d m e t a b o l i s m ( 1 0 . 8 % ) 
n P ro te i n m e t a b o l i s m a n d m o d i f i c a t i o n ( 4 . 3 % ) 
\ B In t race l lu la r p ro te in t raf f ic ( 2 . 5 % ) 
• Ce l l a d h e s i o n ( 3 . 5 % ) 
^ ^ ^ ^ ^ ^ ^ ^ • L ip id, fa t ty a c i d a n d s te ro id m e t a b o l i s m ( 1 . 0 % ) 
• A m i n o a c i d m e t a b o l i s m ( 0 . 5 % ) 
• B i o l og i ca l p r o c e s s u n c l a s s i f i e d ( 8 . 3 % ) 
• P ro te i n t a rge t i ng a n d l o c a l i z a t i o n ( 0 . 5 % ) 
89 
(C) 
• A l an ine b i o s y n t h e s i s ( 1 . 6 % ) 
N S 1 A P a t h w a y • v a l i n e b i osyn thes i s ( 1 .6%) 
e A x o n gu idance m e d i a t e d by S l i t / R o b o ( 3 . 2 % ) 
E J A K / S T A T s igna l ing pa thway ( 8 . 1 % ) 
1 • o A p o p t o s i s s igna l ing pa thway ( 6 . 5 % ) 
\ \ • I / D A n g i o g e n e s i s ( 4 . 8 % ) 
\ 1 I / B In ter leuk in s igna l ing pa thway ( 1 2 . 9 % ) 
I I j j B r 口 丨nterferon-gamma s igna l ing p a t h w a y ( 4 . 0 % ) 
/ I \ • In f lammat ion m e d i a t e d by c h e m o k i n e and c y t o k i n e s igna l ing (16 .9%) 
L ^y^ \ 團 p53 pa thway feecJback loops 2 ( 1 . 6 % ) 
^ \ m p53 pa thway by g l u c o s e depriNation ( 1 .6%) 
^ — • E G F receptor s igna l ing pa thway ( 6 . 5 % ) 
画 P D G F s igna l ing pa thway ( 6 . 5 % ) 
• Ox ida t ive s t r ess r e s p o n s e ( 3 . 2 % ) 
M o R a s P a t h w a y (4 .8%) 
\ / ^ F E Leuc ine b i osyn thes i s ( 1 .6%) 
\ / ^ W 3 B Iso leuc ine b i osyn thes i s ( 1 .6%) 
一 • Hun t ing ton d i s e a s e (1 .6%) 
B i W ^ ^ ^ ^ Z • W n t s igna l ing pa thway (1 .6%) 
^ ^ ^ ^ ^ ^ ^ B Toll receptor s igna l ing pa thway (6 .5%) 
• TGF-be ta s igna l ing pa thway (1 .6%) 
• F A S s igna l ing pa thway (1 .6%) 
Figure 3.5. Classification of N S I A target genes. Analyses of (A) molecular function, 
(B) biological process and (C) signaling pathway were performed using the Panther 
database publicly available at http://www.pantherdb.org. 
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3,2.3.1.1 Effect of NSIA on antiviral sene expression 
In the 100 genes perturbed by NSIA protein, 52 of them were perturbed by NSIA but not 
NSIB. Within the 52 genes, 27 of them, including 10 potential antiviral genes and 12 
IFN-stimulated genes, were down-regulated. A group of virus-activated transcription 
factors, the I FN regulatory factors (IRFs), including IRFl and IRF7, which were suggested 
to be important virus-induced and virus-activated transcription factors (Julkunen et al., 
2001) and were associated with IFN-inducible gene expression (Mamane et al., 1999), were 
down-regulated by NSIA. Other antiviral genes repressed by NSIA included 
IFN-regulated antiviral factors myxovirus (influenza virus) resistance genes (MXl and 
MX2), which have been shown to cause resistance against influenza A viruses (Vanlaere et 
a\., 2008) and a special group of sugar-binding proteins, the mannose-binding lectins. 
Human mannose-binding lectins have previously been shown to inhibit influenza A virus 
infection by blocking viral attachment to host cells and viral release (Kase et al., 1999). 
By down-regulating gene expression of a member of the human mannose-binding lectins, 
LMAN2, NSIA might facilitate the continual spread of influenza viruses. NSIA also 
regulate gene expression of proteins in the N F - K B signaling pathway. It has been 
demonstrated that NSl could sequester dsDNA away from N F - K B to stop its activation 
(Wang et al., 2000), resulting in inhibition of antiviral responses. In this study, gene 
expression of two other proteins in this pathway, NF-KB-inducing kinase (MAP4K4) and 
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lysosomal-associated membrane protein 2 (LAMP2), were found to be repressed by NSl A. 
By inhibiting gene expression of MAP4K4 and LAMP2, NSl A could reduce the level of 
N F - K B activation and the sequential antiviral responses. The inhibited gene expression of 
IRFs, influenza virus resistance genes, lectins and proteins involved in N F K B signaling 
pathway by NSl A might imply new roles of NSl A to antagonize host antiviral responses. 
3.2.3,1.2 Regulation of JAK-STAT pathway by NSIA 
Recent findings showed that NSl could oppose the action of IFNs in multiple levels (Kochs 
et al., 2007). Here we found a new mechanism of NSIA to antagonize IFNs. We 
demonstrated that NSIA perturbed genes in the JAK-STAT pathway. This pathway 
involves cell-surface receptors, cytoplasmic JAKs and STATs. Upon activation by IFNs, 
the STATs will be activated and enter the nucleus, resulting in synthesis of antiviral proteins 
and generation of host antiviral responses. In our experiments, we found that STATl, 
STAT2, STAT3 and STAT4 were repressed by NSIA, indicating that NSIA might have a 
role in impairing the JAK-STAT pathway. Interestingly, two members in the suppressors 
of cytokine signaling (SOCSs) family, SOCSl and S0CS3, were up-regulated. SOCSs 
negatively modulate the JAK-STAT pathway by inhibiting the JAKs and STATs. SOCSl 
inhibits catalytic activities of JAKs by binding to them (Sasaki et al., 1999) and SOCSS 
functions by binding to cell-surface receptors (Hansen et aL, 1999). We demonstrated that 
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N S I A could repress STATs expression and, at the same time, induce SOCSs expression, 
suggesting that these two actions might be functionally linked. Another evidence showing 
the involvement of JAK-STAT pathway was the down-regulation of N-myc (and STAT) 
interactor (NMI), which could interact with STATs and modulate the STAT signaling (Shuai 
et al., 2000). It should be noted that these actions were not found in NSIB and were 
found in N S I A only. 
3.2.3.2 Genes perturbed by NSIB 
72 genes were perturbed by NSIB. These 72 genes were classified for the molecular 
function, biological process and signaling pathway using the Panther database. Among 
the total 29 molecular functions, 31 biological processes and 129 signaling pathway groups, 
13, 19 and 10 groups respectively were hit (Figure 3.6). Among the molecular function 
groups, many hits are in the 'signaling molecule' (28.7%), 'transcription factor' (8.1%) and 
'select regulatory molecule' (8.1%). Among the biological process groups, many hits are 
in the ‘immunity and defense' (26.5%) and 'signal transduction' (20.1%) genes. Among 
the signaling pathway groups, many hits are in the 'inflammation mediated by chemokine 
and cytokine signaling' (30.2%) and ‘interleukin signaling' (15.1%). 
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(A) 
N S 1 B M o l e c u l a r F u n c t i o n 
m R e c e p t o r ( 7 . 4 % ) 
^ • M o l e c u l a r f u n c t i o n u n c l a s s i f i e d ( 1 6 . 9 % ) 
^ ^ k B T r a n s p o r t e r ( 3 . 7 % ) 
^ ^ ^ ^ ^ H S J ^ ^ ^ ^ L 圍丁 ransferase (9.60/0) 
I E M ^ ^ ^ ^ ^ • C h a p e r o n e ( 2 . 2 % ) 
• S i g n a l i n g m o l e c u l e ( 2 8 . 7 % ) 
• S y n t h a s e a n d s y n t h e t a s e ( 1 . 5 % ) 
• N u c l e i c a c i d b i n d i n g (5.1。/。） 
\ m C e l l a d h e s i o n m o l e c u l e ( 5 . 9 % ) 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ H H H ^ H H V 口 D e f e n s e / i m m u n i t y p r o t e i n ( 1 . 5 % ) 
f a c t o r 
• S e l e c t r e g u l a t o r y m o l e c u l e ( 8 . 1 % ) 
(B) 
• S i g n a l t r a n s d u c t i o n ( 2 0 . 1 % ) 
NS1B Biological P r o c e s s nsuifurmetabolism (i.i%) 
B D e \ ^ l o p m e n t a l p r o c e s s e s ( 4 . 9 & ) 
H O t h e r m e t a b o l i s m ( 1 . 5 % ) 
• Ce l l p ro l i fe ra t ion a n d d i f f e ren t ia t i on ( 4 . 1 % ) 
• Ce l l s t r u c t u r e a n d mo t i l i t y ( 5 . 2 % ) 
\ m I m m u n i t y a n d d e f e n s e ( 2 6 . 5 % ) 
\ • A p o p t o s i s ( 1 0 . 4 % ) 
H O n c o g e n e s i s ( 1 . 1 % ) 
• T ranspor t ( 1 . 9 % ) 
B P h o s p h a t e m e t a b o l i s m ( 0 . 7 % ) 
7 • C a r b o h y d r a t e m e t a b o l i s m ( 1 . 1 % ) 
？ r a N u c l e o s i d e , n u c l e o t i d e a n d n u c l e i c a c i d m e t a b o l i s m ( 4 . 9 % ) 
cycle (1.9%) 
m H H m ^ B P ro te i n m e t a b o l i s m a n d m o d i f i c a t i o n ( 2 . 6 % ) 
m Ce l l a d h e s i o n ( 3 . 0 % ) 
^ ^ ^ ^ ^ B L ip id , fa t ty a c i d , s t e r o i d m e t a b o l i s m ( 1 . 1 % ) 
• A m i n o a c i d m e t a b o l i s m ( 1 . 1 % ) 




/ • A x o n gu idance m e d i a t e d by S l i t /Robo (5 .7%) 
^ ^ m ^ ^ ^ H ^ ^ B / \ • Inter leukin s igna l ing pa thway ( 1 5 . 1 % ) 
y ^ ^ H j j i p f l p ^ l ^ H ^ J / \ n A p o p t o s i s s igna l ing pa thway ( 1 1 . 3 % ) 
/ ^ " " ^ ^ ^ ^ J I I I ^ B / \ H In f lammat ion by c h e m o k i n e and c y t o k i n e s igna l ing (30 .2%) 
/ a W n t s igna l ing pa thway (5 .7%) 
• Va l i ne b i osyn thes i s ( 5 . 7 % ) 
\ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ / hToII receptor s igna l ing pa thway (9 .4%) 
Figure 3.6. Classification of NSIB target genes. Analyses of (A) molecular function, 
(B) biological process and (C) signaling pathway were performed using the Panther 
database publicly available at http://www.pantherdb.org. 
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3.2.3.2.1 Effects of NSlB on IFN-stim ulated sen e expression 
In the 72 genes perturbed by NSIB protein, 24 of them were perturbed by NSIB but not 
NSIA. Within the 24 genes, 10 of them, including three potential antiviral genes and two 
IFN-stimulated genes (ISGs), ISG15 and ISG20, were down-regulated. Synthesis of 
ISG15 protein was induced during influenza B virus infection. However, little or no 
ISG15 protein was produced in human lung cells infected by influenza A virus (Yuan et al., 
2001). There was also evidence that NSIB but not NSIA could interact with ISG15 
(Yuan et al., 2001). Our data suggested a new role of NSIB to antagonize ISG15. In 
addition to interacting with ISG15 to block the covalent linkage of ISG15 to its target 
proteins (Yuan et al., 2002), NSIB could also regulate the gene expression of ISG15. 
3.2.3.3 Genes perturbed by both NSIA and NSIB 
48 genes with more than 2-fold changes and more than 99% confidence were regulated by 
both NSIA and NSIB proteins. Within the 48 genes, 40 genes, including 15 potential 
antiviral genes and 10 IFN-inducible genes, were down-regulated. Within the 15 potential 
antiviral genes, there was a special group of interest, the TNF-related genes. Seven 
members of it, including TNF, TNFAIP2, TNFSF9, TNFSFIO, TNFSF13B, TNFSF14 and 
TNFSF18 were down-regulated. These genes were related to apoptosis and antiviral 
responses, indicating that NSIA and NSIB might have a role in TNF-related apoptosis. 
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In addition, three members in the group of carcinoembryonic antigen-related cell adhesion 
molecules (CEACAMs) were also down-regulated. They belong to a group of 
mammalian immunoglobulin-related glycoproteins modulating the immune responses 
associated with infection, inflammation and cancer, implying new potential targets of NSl A 
and N S I B to mediate inflammatory responses. 
Besides the antiviral and IFN-inducible genes, NSIA and NSIB regulated expression of 
cytokine genes. NSl A and NSIB inhibited gene expression of IFN-a (IFN-a6, IFN-al3, 
IFN-a l6 , IFN-a l7 ) and IFN-p (IFN-pl). Pro-inflammatory ILs like ILlp , IL6 and IL8, 
and other ILs and IL receptors, including IL7R, IL15Ra, IL28 and IL29, were also 
down-regulated by N S I A and NSIB proteins, indicating that both NSIA and NSIB 
proteins were able to repress the gene expression of pro-inflammatory cytokines. One IL 
of interest was ILIO. Unlike the previously mentioned pro-inflammatory cytokines, 
whose gene expression were inhibited, gene expression of this anti-inflammatory cytokine 
was induced, and its gene expression was induced by NSIA but not NSIB. We showed 
that both NSIA and N S I B could repress gene expression of pro-inflammatory cytokines, 
while only NSl A could induce anti-inflammatory ILIO. 
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3.2.4 Verification of differentially expressed genes 
To provide confidence for the interpretation of the microarray data sets, the microarray 
results were verified by QRT-PCR. 11 genes including seven cytokines, two genes in the 
JAK-STAT pathway and two antiviral genes were compared. QRT-PCR was performed as 
described in Section 2.2.7. Table 3.5 summarizes the results obtained by QRT-PCR and 
microarray analyses. The detailed data are shown in Table 4.1 and Figure 4.3 in Chapter 4. 
The fold change found in microarray and QRT-PCR presented was the mean of results in 
two and three independent experiments respectively. As shown in Table 3.5, the 
QRT-PCR results were consistent with the microarray results. 
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Table 3.5. Comparison of microarray and QRT-PCR results. 
Fold change found in microarray Fold change found in QRT-PCR 
Genes NSIA NSIB NSIA NSIB 
IFN-a ^^T^ ^ T ^ T T o ^ 
IFN-p ^ ^ ^ ^ 
TNF-a ^ ^ ^ ^ 
l u p ^ ^ ^ ^ 
IL6 ^ ^ ^ ^ 
l U O / ^ 
i u s ^ ^ ^ T 3 
STATl ^ / ^ / 
S0CS3 + 4 ^ / / 
O A ^ ^ ^ 
I S ^ / ^ / ^ 
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3.3 Discussion 
3.3.1 Human lung epithelial cell line as a model 
A human lung epithelial cell line NCI-H292 was used in this study. Lung epithelial cells 
are the primary infection sites during influenza virus infection. We believe this cell line 
might more accurately represent the physiological sites of influenza virus infection. 
Previously, most of the in vitro studies on influenza virus-induced gene expression 
alterations were performed in whole virus- or recombinant virus-infected cell lines (Geiss 
et al., 2002; Shimizu et al., 2004). In our experiments, NSl proteins were transiently 
transfected into NCI-H292 cells. Although we could not rule out that this model might 
not represent the physiological status during influenza virus infection, this experimental 
approach allowed us to demonstrate the importance of NSl protein for regulating host cell 
gene expression. We demonstrated that NSl protein indeed was crucial in regulating the 
host antiviral responses by inhibiting cytokines, IFNs, JAK-STAT pathway and other 
antiviral genes. 
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3.3.2 DNA microarray technology 
DNA microarray technology is becoming increasingly popular for examining the effect of 
viral infection on gene expression of host cells and for comparing host cell responses to 
different pathogens. Using this technology, expression of tens of thousands of genes can 
be detected simultaneously. This approach allowed us to identify genes associated with 
different functions and pathways. In this study, we have explored the possibility of using 
microarray analyses to investigate the roles of viral protein NSl in the viral pathogenesis. 
QRT-PCR is often regarded as a good way for validation of DNA microarray and 
measurement of gene expression (Shi et al., 2005). Our validation results demonstrated a 
strong consistence between microarray and QRT-PCR analyses, suggesting that our 
microarray method had high reliability and reproducibility for detection of host cell gene 
expression profiles induced by NSl proteins. 
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3.3.3 Different action of NSIA and NSIB on host cell gene expression 
NSl protein was previously shown to inhibit the production of IFN-p in infected cells, 
including epithelial cells and dentritic cells (Lopez et aL, 2003). This feature allows 
influenza viruses to escape from the host innate immunity. We showed that the inhibitory 
effect by the NSl protein on antiviral responses was not a global effector simply the result 
of inhibition of IFN-a/p release and signaling. Numerous genes were not affected or only 
moderately affected by the presence of the NSl protein. 
NSIA has been described as a multi-functional protein mediating different effect on cells 
after virus infection. It has been shown to inhibit pathways involved in IFN-P production 
(Bergmann et al., 2000; Donelan et aL, 2003 and Lu et aL, 1995) and the activation of the 
transcription factors like N F - K B , A P - 1 , I R F 3 and I R F 7 (Smith et al” 2 0 0 1 ) . We 
hypothesized that NSIA and NSIB, having distinct amino acid sequences and functions, 
might mediate different antiviral responses. We identified genes associated with antiviral 
pathways. Interestingly, host cell gene expression profiles for NSIA and NSIB were 
different. Action of NSIA and NSIB on host cell gene expression differed mainly in 
three aspects. First, expression of multiple members in the JAK-STAT pathway was 
regulated by NSIA but not NSIB, showing that only NSIA can impair the IFN-induced 
signal transduction via the JAK-STAT pathway. Second, IFN-stimulated gene ISG15 was 
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down-regulated by N S I B but not NSIA, showing that this inhibition was unique in NSIB 
protein. Third, cytokine genes perturbed by NSIA and N S I B were different. The 
different cytokine expression profiles induced by different NSl proteins will be discussed 
in detail in Chapter 4, and the different roles of NSIA and N S I B will be discussed in the 
following sections. 
3.3.4 Novel roles of NSIA 
We demonstrated that gene expression of multiple members in the JAK-STAT pathway was 
regulated by N S I A but not NSIB. Upon binding of IFN-a/p subtypes to its receptor, the 
JAK-STAT signaling pathway is activated, resulting in expression of IFN-stimulated genes 
(De Veer et al., 2001; Samuel et al., 2001). The STATs provide positive feedback 
regulation in the I FN system for the induction of cytokine and chemokine gene expression, 
leading to antiviral responses (Ronni et al., 1997). An important negative modulator of 
this pathway is the SOCS, which was shown to inhibit JAKs and STATs (Hansen et al., 
1999; Sasaki et al., 1999). In this study, we demonstrated that NSIA alone could 
down-regulate STATs gene expression. However, STATs were shown to be activated 
during influenza A virus infection (Matikainen et al., 2000). Recently, microarray 
experiments have been performed by Sarmenta et al. to study the gene expression levels in 
chicken embryo fibroblasts infected with avian influenza A viruses. It was found that 
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gene expression of a member of JAKs and two members of STATs, STATS and STAT5, 
were induced during influenza A virus infection (Sarmenta et al., 2008). These findings 
show that activation of JAK-STAT was observed in whole virus model. The discrepancy 
in the findings of Sarmenta et al. and our findings might be due to the different responses 
of host cells during whole virus infection and single protein transfection. Further 
investigation is needed to verify this issue. We demonstrated that N S I A alone could 
down-regulate STATs gene expression and at the same time up-regulate SOCSs gene 
expression, suggesting that these two actions might be functionally linked. Our findings 
suggested a new mechanism of N S I A to circumvent cellular antiviral strategies — by 
impairing the IFN-induced signal transduction via the JAK-STAT pathway (Figure 3.7). 
Indeed, similar mechanism has been described for proteins of other viruses. Core protein 
in hepatitis C virus was found to inhibit activation of STATl and induce SOCSS mRNA 
production in hepatic cells (Bode et al., 2003). 
Other novel potential targets of N S I A identified included antiviral factors myxovirus 
(influenza virus) resistance genes (MXl and MX2), mannose-binding protein (LMAN2), 
NF-KB-inducing kinase (MAP4K4) and lysosomal-associated membrane protein 2 
(LAMP2). Down-regulation of all of these genes except MAP4K4 was unique in NSIA. 
MAP4K4 and LAMP2 are involved in N F - K B signaling pathway. Activation of N F - K B 
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signaling pathway results in antiviral responses. Studies have demonstrated that NSl 
could sequester dsDNA away from N F - K B to stop its activation (Wang et al., 2 0 0 0 ) . In 
this study, two proteins in this pathway, MAP4K4 and LAMP2, were found to be regulated. 
By inhibiting expression of MAP4K4, which could induce N F - K B activation, the level of 
N F - K B activation and the sequential antiviral responses could be reduced. On the other 
hand, by inhibiting expression of LAMP2, lysosomal degradation of the inhibitor of N F - K B 
would decrease, resulting in increased inhibition and decreased activation of N F - K B . 
Other genes of interest were RIG-I and OAS. RIG-I and OSA have recently been 
identified as two of the key intracellular sensors of viral infection (Sen et al, 2000; 
Yoneyama et al., 2004). It was suggested that the primary roles of NSIA protein in 
virus-infected cells was to sequester dsRNA away from N F - K B , R I G - I and OAS to inhibit 
their functions (Guo et al., 2007; Min et al., 2006; Wang et al., 2000). In our study, we 
demonstrated that besides sequestering dsRNA, NSIA could antagonize antiviral responses 
in transcriptional level by regulating antiviral gene expression. Similar mechanism has 
been described for proteins of other viruses. For example, X protein in hepatitis B virus 
was found to be able to modify viral and cellular transcription by regulation of signal 
transduction pathways and a variety of viral and cellular promoters (Doria et al., 1995; 
Seeger et al., 2007). 
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Figure 3.7. Schematic diagram of the perturbation of the JAK-STAT pathway by 
NSIA protein. The binding of interferon to cell surface receptor causes receptor to 
dimerize. The associated JAKs are then activated and recruit different STATs. The 
activated STATs enter the nucleus to bind to specific DNA sequences and induce the 
transcription of adjacent genes, leading to antiviral responses (Matikainen et al., 2000; 
Ronni et al., 1997). An important negative modulator of this pathway is the SOCSs, 
which were shown to inhibit JAKs and STATs (Hansen et al., 1999; Sasaki et al., 1999). 
We demonstrated that NSIA could down-regulate STATs gene expression and at the same 
time up-regulate SOCSs gene expression, suggesting a new mechanism of NSIA to 
circumvent cellular antiviral strategies - by impairing the IFN-induced signal transduction 
via the JAK-STAT pathway. 
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3.3.5 Novel role of NSIB 
Study has shown that various strains of influenza B virus could induce protein synthesis of 
IFN-stimulated gene ISG15 in influenza virus-infected cells, but influenza A virus could 
not, suggesting that this property is probably shared by all influenza B virus (Yuan et al., 
2001). One explanation can be proposed for the virtual absence of ISG15 protein in 
influenza A virus-infected cells. The binding of the NSIA effecter domain to the 30kDa 
subunit of CPSF and to PABII could inhibit the nuclear export of mRNA encoding 
IFN-induced proteins (Fortes et aL, 1994; Qiu et al., 1994; Satterly et al., 2007). Like the 
mRNA of other IFN-induced proteins, the newly synthesized ISG15 pre-mRNA and mRNA 
are trapped in the nucleus and degraded. Consequently, little or no ISG15 mRNA can 
survive and exported to cytoplasm, and little or no ISG15 protein can be synthesized in 
influenza A virus-infected cells. On the other hand, because N S l B is not able to inhibit 
nuclear export of mRNA, ISG15 protein will be synthesized in influenza B virus-infected 
cells. Although influenza B virus can induce synthesis of ISG15 protein in virus-infected 
cells, the presence of N S I B has been shown to antagonize ISG15. There was evidence 
that NSIB but not N S I A could interact with ISG15 to block the covalent linkage of ISG15 
to its target proteins in infected cells (Yuan et al., 2002). In addition to interacting with 
ISG15, our data suggested another role of NSIB to antagonize ISG15. We demonstrated 
that NSIB could inhibit the gene expression of ISG15, and this transcriptional inhibition 
was unique in NSIB protein. However, previous studies have shown that influenza B 
virus can induce synthesis of ISG15 (Yuan et al,, 2001). Further investigation is needed 
to verify this discrepancy. Although NSIB cannot completely stop the production of 
ISG15 protein like NSIA, it may be able to reduce the level of ISG15 by inhibiting its 
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transcription. By reducing the level of ISG15, NSIB may reduce viral clearance and 
facilitate continual viral replication in host cells. The mechanism of NSIB to repress 
ISG15 gene expression has not been identified. In addition, it is still not known how the 
inhibition of ISG15 transcription affects the replication of influenza B virus. Future 
experiments are needed to resolve this issue. 
3.3.6 Implications 
Like other important antiviral proteins, NSl protein is produced during the early phase of 
infection (Shapiro et al., 1987). The transcriptional modulation by NSl to circumvent the 
host antiviral responses may be important especially during the early phase of infection and 
viral replication. The ability of the viruses to escape from clearance by the host antiviral 
defense, so as to enable the virus to propagate, may be a critical factor for pathology and 
disease severity. Our data demonstrated the stronger and more comprehensive 
immunosuppressive effects of NSIA than NSIB. These findings will lay the foundation 
of selection for new antiviral compounds against pathogenic strains of influenza viruses 
and the development of new generation of safe and immunogenic live influenza virus 
vaccines in the future. 
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Chapter 4 
Roles of NSl A，NSIB and NSIC on cytokine expression 
4.1 Introduction 
There is now growing evidence that cytokines produced at the site of influenza virus 
infection is related to the pathogenecity. Cytokines belong to a group of low molecular 
weight proteins or glycoproteins produced by both immune and non-immune cells. One 
major function of cytokines is to regulate immune responses. They are local hormones 
that modulate activities of cells, especially within the immune system. Cytokines are 
rapidly produced after influenza virus infection by epithelial and immune cells in the 
respiratory mucosa. Lung epithelial cells, which are the primary sites of influenza virus 
infection, are one of the sources of pro-inflammatory cytokines and chemokines. 
Cytokines derived from lung epithelial cells have been shown to play an important role in 
regulating airway inflammation (Gem et al., 2003). Dysregulation of cytokines during 
influenza virus infection is believed to be important mediator of pathology and disease 
severity. Avian H5N1 virus is a potent cytokine inducer, especially for TNF-a and IFN-p. 
Heightened cytokine production is thought to be responsible in part for the increased 109 
mortality observed in patients (Szretter et al., 2007). H5N1 virus prompts unregulated 
cytokine production in macrophages, resulting in 'cytokine storm' (Barry, 2004), leading to 
tissue damages in the infected host (Cheung et al., 2002). 
NSl contributes to viral virulence by allowing the virus to evade I FN responses in host 
cells (Garcia-Sastre et aL, 2001; Garcia-Sastre et aL, 2006; Krug et aL, 2003). Studies 
demonstrated that NSl protein could circumvent the antiviral effects of IFNs and TNF-a, 
resulting in enhanced replication in, and reduced clearance from, the infected cells (Seo et 
aL, 2002; Seo et al., 2004). In addition, it was found that NSl could mediate disruption of 
cytokine network and might be accounted for part of the lung lesions (Cheung et al., 2002; 
Lipatov et al., 2005). Recombinant H l N l virus with the NS gene of 1997 H5N1 virus 
was found to be more pathogenic in pigs, possibly by escaping or counteracting the host 
antiviral responses of IFNs and TNF-a, which are critical for the body's defense against 
viral infection (Seo et al., 2002). In influenza A virus-infected human macrophages, NSl 
protein was found to involve in the inhibition of pro-inflammatory cytokines such as 
TNF-a, IL6 and M l P - l a (Stasakova et al, 2005). Another study demonstrated that like 
NSIA, NSIB was also involved in the inhibition of IFN-P expression (Dauber et al., 2004). 
Recent findings suggest that NSIA, being an effective IFN antagonist (Garcia-Sastre et al., 
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1998; Krug et a/., 2003), is essential to overcome the innate antiviral cytokine response of 
the host (Fernandez-Sesma et al., 2007). In Chapter 3, we showed that the inhibitory 
effect by the NSl proteins on antiviral responses is not a general effector just the result of 
inhibition of IFN-a/p release and signaling. Therefore, we hypothesize that NSIA might 
also be involved in the control of gene expression of other cytokines, such as those involved 
in the regulation of immunity (for examples, IL6, IL12) and inflammation (for examples, 
ILip, IL8, ILIO). Although NSIA and NSIB proteins share little amino acid sequence 
homology, like N S I A protein, NSIB protein is also able to inhibit the activation of the 
IFN-induced protein kinase (PKR) and binds to dsRNA in vitro (Dauber et al., 2004) as an 
I FN antagonist. It led us to hypothesize that, like NSIA protein, NSIB and NSIC 
proteins might also be involved in the control of gene expression of other cytokines related 
to pathogenesis. The degree of virulence might depend on the sequence of the gene 
encoding NS l . Thus, influenza virus encoding a 'strong' NSl protein would be expected 
to more efficiently down-regulate innate immunity to allow viral replication. Less 
pathogenic influenza types like influenza B and C viruses might have 'weak, NSl proteins 
that are less proficient to circumvent host defense. Therefore, compared to NSIA protein, 
NSIB and NSIC proteins might be less effective to overcome the innate antiviral cytokine 
response of the host. In this Chapter, to reveal the possible roles of different NSl proteins 
in cytokine gene expression, gene expression of a panel of important cytokines induced by 
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NSIA, N S I B and N S I C proteins were examined by QRT-PCR. The different cytokine 
gene expression patterns induced by NSIA, N S I B and N S I C proteins might explain the 
distinct virulence and pathogenesis of influenza A, B and C viruses. 
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4.2 Results 
4.2.1 NSl protein expression in transfected NCI-H292 cells 
Human lung epithelial cell line NCI-H292 was transfected with empty plasmid or plasmid 
containing NSl genes from influenza A/Hong Kong/156/97(H5Nl), influenza B/Hong 
Kong/692/01 or influenza virus C/Hong Kong/6/07. At 4 h and 24 h post-transfection, 
cells were collected. Expression of NSIA, NSIB and N S I C proteins were confirmed by 
Western blots. No NSl protein expression was detected in non-transfected cells or cells 
transfected with empty plasmid in both time points (Fig 4.1). 
4.2.2 Purity and integrity of total RNA extracted 
Total RNA samples were extracted from transfected and non-transfected NCI-H292 cells at 
4 h and 24 h post-transfection using TRIzol reagent (Invitrogen) according to the 
manufacturer's protocols. RNA integrity was determined by electrophoresis in 1.5% 
agarose gels with ethidium bromide staining. RNA extracted from transfected and 
non-transfected NCI-H292 cells showed high integrity (Figure 4.2). Apart from that, 
purity of RNA was determined by optical density measurement by measuring the 
OD260/OD280 ratios. The OD260/OD280 ratios for total RNA extracted from pCIneo-, 
pClneo-NSlA-, pCIneo-NSlB- and pCIneo-NS 1 C-transfected and non-transfected cells 
were within 1.8 to 2.0, showing that the RNA quality was good. 
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4 h 24 h post-transfection 
(A) Non-transfected 
(B) Empty plasmid (pClneo) 
(C}pClneo-NS1A 一 < _ 26 kDa NS1A 
(D)pClneo.NS1B ^ ' ^ ~ 31 kDaNSIB 
(E) pClneo-NS1C 28 kDa NSIC 
Figure 4.1. Expression of NSl proteins in NSl-transfected NCI-H292 cells. 
Western blot analysis was performed on the protein lysates of pCIneo-NS 1 -transfected or 
non-transfected NCI-H292 cells. Equal amount of protein lysate was loaded to each lane. 
NSIA, N S I B and N S I C proteins were detected by anti-NSlA, anti-NSlB and anti-NSlC 
rabbit antibodies as single protein bands with sizes of about 26, 31 and 28 kDa respectively. 
Whole cell lysates were prepared from: (A) non-transfected control cells, (B) 
pCIneo-transfected cells, (C) pCIneo-NSl A-transfected cells, (D) 
pCIneo-NSlB-transfected cells and (E) pCIneo-NS 1 C-transfected cells. 
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Figure 4.2. Determination of integrity of total RNA extracts. Integrity of the total 
RNA extracted was confirmed by electrophoresis in 1.5% agarose gels with ethidium 




To find the effects of NSl proteins on cytokine gene expression, NCI-H292 cells were 
transfected with plasmids containing NSIA, NSIB, N S I C genes or empty plasmid. Gene 
expression of a panel of cytokines including IFN-a, IFN-P, TNF-a, ILlp , IL6, ILIO and 
IL18 were analyzed using QRT-PCR 24 h post-transfection. NSIA and NSIB proteins 
were able to repress the gene expression of pro-inflammatory cytokines IFN-a, IFN-p, 
TNF-a, IL lp , IL6 and IL18, but NSIC failed to inhibit gene expression of them. NSIA 
exerted significantly more inhibitory effects on the gene expression of IFN-a, IFN-p, 
TNF-a, ILip , IL6 and IL18. NSIA, NSIB and NSIC demonstrated interesting 
differences in the induction of the anti-inflammatory cytokine ILIO. In NSl A-transfected 
cells, gene expression of this cytokine was induced six fold, whereas NSIB and NSIC did 
not induce gene expression of this cytokine. Figure 4.3 and Table 4.1 show fold changes 
of cytokine gene expression affected by NSIA, NSIB and NSIC. 
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Table 4.1. Fold changes of target cytokines induced by NSl proteins. 
Genes Fold change by NSIA Fold change by NSIB Fold change by NSIC 
IFN-a ^TTO ^ -1.8 
IFN-p ^ ^ -1.1 
TNF-a ^ ^ -1.7 
I L i p ^ ^ ^ 
IL6 ^ ^ ^ 
ILTO -1.3 -1.5 
IL18 ^ h ^ 
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4.3.1 Human lung epithelial cell line as a model for cytokine study 
Airway epithelial cell models have been used extensively to identify important features of 
virus replication for influenza viruses (Arndt et al, 2002; Chan et al., 2005; Choi et aL, 
1992; Endo et al., 1996; Herold et al., 2006; Ibricevic et al., 2006; Matrosovich et al., 
2004; Newby et al., 2006; Slepushkin et al., 2001; Thompson et al., 2006). A human 
lung epithelial cell line NC1-H292 was used in this study. Lung epithelial cells are the 
primary infection sites during influenza virus infection. We believe this cell line might 
more accurately represent the physiological sites of influenza virus infection. Lung 
epithelial cells are one of the sources of pro-inflammatory cytokines and chemokines. 
Cytokines derived from lung epithelial cells have been shown to play an important role in 
regulating airway inflammation (Gern et al., 2003). Our data suggested that NSIA was 
a critical regulator of cytokine regulation in lung epithelial cells. 
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4.3.2 Implications of different cytokine patterns induced by different 
NSl proteins 
In this study, experiments were performed to provide a more comprehensive view of the 
cytokines regulated by NSIA, N S I B and N S I C proteins in human lung epithelial cells. 
Our data implied that N S I A protein could repress gene expression of pro-inflammatory 
cytokines and induce gene expression of anti-inflammatory cytokine. Interestingly, 
cytokine genes perturbed by NSIA, N S I B and NSIC were different. Consistent with 
recent findings showing that both NSIA and N S I B were IFN antagonists (Dauber et al., 
2004; Dauber et al., 2006; Krug et al., 2003), we found that both NSIA and NSIB could 
down-regulate IFN-p gene expression. Another study demonstrated that NSIA protein 
was involved in the inhibition of not only IFN, but also other pro-inflammatory cytokines, 
like TNF-a, IL lp , IL6 and IL18 (Stasakova et al., 2005). Our data was consistent with 
these findings, and in addition to this, we also found that, like NSIA, NSIB could also 
inhibit gene expression of pro-inflammatory cytokines, but the changes induced by NSIB 
was less significant. On the other hand, NSIC exerted only very little inhibitory effect 
on the pro-inflammatory cytokines. The pro-inflammatory cytokines form a complex 
positive feed-back network, resulting in inflammatory and antiviral responses (Julkunen 
et al., 2001). The inhibition of pro-inflammatory cytokines by NSl might be essential 
for productive replication of influenza viruses in the host cells. 
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In the early phase of infection, IFN-p and TNF-a are induced and serve as the first line of 
antiviral defense (Ennis et al., 1981; Fritz et aL, 1999; Green et al., 1982). The 
clearance of influenza viruses in human was shown to be closely related to the amount of 
circulating IFNs and TNF-a (Fritz et aL, 1999). NS gene of H5N1 virus was found to 
be associated with the resistance of antiviral effects of IFN-P and TNF-a (Seo et al., 
2002). Our data suggested that NSIA and NSIB could block the gene expression of 
IFN-P and TNF-a, possibly helping the virus to survive with the cellular IFN-P and 
TNF-a systems, resulting in enhanced replication in, and reduced clearance from, the 
infected cells. 
IL ip and IL18 are members of the class of major regulators of the antiviral immune 
response (Nakanishi et aL, 2001). Influenza A virus-infected ILip and IL18 knockout 
mice demonstrated a higher mortality rate than control mice, indicating that ILip and 
IL18 were important for host antiviral defense (Kozak et al., 1995; Liu et aL, 2004). 
Since IL ip and IL18 can positively regulate immune responses, decreased gene 
expression of IL ip and IL18 by NSIA and NSIB proteins might inhibit a robust immune 
response (Bradney et al., 2002; Staats et al., 2001). 
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IL6 is a prototypic pro-inflammatory cytokine playing critical roles in acute-phase reactions 
and host defense processes (Houssiau et aL, 1992). It is induced by infectious and 
inflammatory agents, including influenza viruses (Conn et aL, 1995; Peschkc et al., 1993). 
Aberrant transcription of IL6 has been shown to associate with a variety of autoimmune 
and chronic infectious or inflammatory proliferative diseases (Brown et al., 2006; Swaak et 
al., 1988). A study using IL6 knock-out mice showed decreased inflammatory responses 
when the mice were challenged with mouse-adapted live influenza virus (Kozak et aL, 
1997), suggesting a pro-inflammatory role of IL6 during influenza virus infection. The 
repressed gene expression of IL6 induced by NSIA and NSIB proteins might inhibit 
inflammatory responses, resulting in circumvention of the host defense and enhanced viral 
replication. 
Interestingly, an anti-inflammatory cytokine ILIO was perturbed only by NSIA. ILIO is 
known to suppress the transcription of lipopolysaccharide-induced inflammatory 
cytokines (Hamilton et al., 2002; Moore et al., 2001). Unlike other pro-inflammatory 
cytokines, gene expression of ILIO was induced. The same was not found in NSIB- and 
NSl C-transfected cells, indicating that only NSIA could activate ILIO production. In S. 
pneumoniae infection of the primary airways, endogenously produced ILIO impaired host 
defense (van der Poll et aL, 1996). Similarly, in murine Klebsiella pneumoniae 
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pneumonia, ILIO circumvented adequate immune responses (Greenberger et al., 1995). 
These findings led us to suggest that the elevated expression level of ILIO in 
NSl A-transfected cells might be important for the impairment of defense against 
influenza viruses. 
In the case of H5N1 virus, post-mortem reports suggested that virus replication in the 
respiratory tract caused high elevation of cytokines, resulting in hypercytokinemia, which 
was the chief cause of death (To et al., 2001). It is possible that hypercytokinemia was 
induced by influenza virus that escaped the antiviral effects of cytokines and continued to 
replicate until the number of virus reached a very high level. The ability of the virus to 
escape from the host antiviral defense, and thus continue to replicate and cause more 
severe diseases might be a critical factor for pathology and disease severity. Among the 
three NSl proteins investigated in this study, NSIA inhibited gene expression of the 
pro-inflammatory cytokines to the greatest extent, while NSIB and NSIC exerted less 
effect on the cytokines. These data pointed to an immunosuppressive role of NSIA. 
The strongest immunosuppressive effects of NSIA might explain the highest 
pathogenesis and disease severity of influenza A virus. 
NSIA, being able to inhibit pro-inflammatory cytokines and activate anti-inflammatory 
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cytokine, may help antagonize the host inflammatory and antiviral responses, and to 
facilitate continuous virus replication. Regulation of pro- and anti-inflammatory 
cytokine gene expression may be a mechanism that allows influenza virus to survive in 
cells and continue to replicate. The findings in this study will lay the foundation in the 
development of new therapeutic drug targets against influenza virus in the future. 
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Chapter 5 
General Discussion and Future Perspectives 
The ability of the influenza virus to escape from clearance by the host antiviral defense, and 
thus continue to replicate to cause severe diseases is a critical determinant for pathology 
and disease severity. It is believed that NSl protein is an essential viral regulator to 
facilitate viral survival and replication in host cells. In this study, a human lung epithelial 
cell line NCI-H292 was used as a model and microarray and QRT-PCR analyses were 
performed to demonstrate whether NSl protein alone is sufficient to regulate host cell gene 
expression and to compare different activities of NSl A, NSIB and NSIC proteins. 
Microarray technologies allowed us to perform large-scale gene expression studies to 
investigate tens of thousands of genes simultaneously. Our microarray results showed that 
the NSIA protein alone could circumvent the host antiviral response in human lung 
epithelial cells by inhibiting cytokines, IFNs, J A K - S T A T pathway, N F - K B signaling 
pathway and other antiviral genes. The inhibitory effect by the NSl protein on antiviral 
responses was neither a global effect nor simply the result of inhibition of IFN-a/p release 
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and signaling. Interestingly, clear differences were found in cellular gene expression 
profiles induced by N S I A and N S I B proteins, suggesting that these two proteins adopt 
different specific strategies to antagonize the host defense. Our data demonstrated NSIA 
has a stronger and more comprehensive immunosuppressive effect than NSIB. These 
differences might explain the higher virulence, pathology and disease severity of influenza 
A viruses. 
We further investigated the virulence characteristics of NSl proteins from different types of 
influenza viruses by examining the cytokine gene expressions by QRT-PCR. Among 
NSIA, NSIB and N S I C proteins, NSIA protein inhibited gene expression of the 
pro-inflammatory cytokines to the greatest extent, while NSIB and NSIC proteins exerted 
fewer effects on the cytokines. These data pointed to an immunosuppressive role of NSl A. 
The strongest immunosuppressive effects of NSIA protein may explain the highest 
pathogenecity and disease severity of influenza A viruses. Interestingly, we also 
demonstrated that N S I A was able to induce the gene expression of an anti-inflammatory 
cytokine ILIO. This may help antagonize the host inflammatory and antiviral responses, 
and to facilitate continuous virus replication in virus-infected cells. Regulation of pro-
and anti-inflammatory cytokine gene expressions may be one of the mechanisms that allow 
influenza virus to survive in host cells and continue to replicate. 
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Our findings demonstrated the transcriptional modulation ability of NSl protein. Because 
influenza virus infection is known to repress the translational level of cellular proteins in 
influenza virus-infected cells, future experiments are needed to assess the combined effects 
of translational inhibition of global protein expression with changes in cellular RNA level. 
Besides, one of the major challenges is to solve the genetic basis of viral virulence. It will 
be interesting to compare the cellular gene expression patterns induced by NSl proteins 
from different influenza virus subtypes like H l N l and H3N2. Although the influenza 
virus subtypes have common strategies of replication, they have different pathologies and 
have developed specific strategies to counteract the host antiviral responses. For example, 
virulent H5N1 subtype of influenza virus often harbors a unique D92E point mutation in 
the NSl protein. This crucial mutation was correlated with increased virulence and 
cytokine resistance (Li et al., 2007). On the other hand, unlike most other NSl proteins 
from human strains of influenza, the NSl sequence of the 1918 H l N l pandemic influenza 
virus contains a class II consensus SH3-binding sequence, which is important for host cell 
signaling modulation (Heikkinen et al., 2008). This comparison would greatly add to our 
understanding of the relationship between genetic basis and the virulence of influenza 
viruses. It is also important to identify domains or amino acids in NSl proteins that are 
critical for counteracting host defense. Differences in structures of NSIA, NSIB and 
NSIC proteins may explain their distinct cellular gene expression profiles induced. 
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Structures of N-terminal RNA-binding domain and C-terminal effecter domain of NSIA 
protein have been solved previously (Bornholdt et al., 2006; Liu et al., 1997). To have a 
more complete understanding of the structure-function relationship of NSIA, NSIB and 
NSIC proteins, further experiments are needed to solve the structures of NSIB and NSIC 
proteins. 
We demonstrated a significant immunosuppressive role of NSl protein. These findings 
encourage further investigation into the potential of NSl protein as a novel therapeutic drug 
and modified live-virus vaccines (MLV) target. Attempt could be made to develop new 
strategies directed at unexplored targets like NSl . Future studies on signaling 
intermediates and pathways modulated by NSl may identify important targets for 
therapeutic intervention. Critical regions in NSl can also be considered as points of attack 
for chemotherapeutic intervention. In addition, the generation of influenza virus with 
mutation in NSl may provide novel possibilities for the development of modified 
live-influenza virus vaccine. Studies have shown the ability of a NSl C-terminal deletion 
MLV to protect pigs against swine influenza (Richt et al., 2006; Vincent et al, 2007), 
suggesting the potential use of NSl-based MLV. 
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